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Document purpose
To build upon the findings of the three NCCDP briefings [Drug
prevention in vulnerable young people, Tiered approach to drug
prevention and treatment and Universal drug prevention] by
presenting, categorising and grading research findings and
identify gaps in the evidence. An additional purpose is to
introduce the reader to the economics of drug prevention.
Target audience
The report is of relevance to following three broad groups of
professionals:
 Executives, senior managers, commissioners and budget
holders.
 Service providers.
 Community-based professionals.
 Academics, designers, planners and evaluators of drug
prevention projects.
Description
Presents and grades the evidence in relation to drug prevention
in young people across the four tiered model of services.
Key recommendations and gaps are presented according to
their relevance to different professional groups. Discusses the
economics of drug prevention and introduces the methods of
economic evaluation in relation to the field.
Reader objectives
 The evidence base underlying key government policy.
 Gain an overview of evidence based approaches to drug
prevention.
 Learn about gaps in the current evidence base, and how
to resolve them.
 Learn about key issues in economic evaluation of drug
prevention.
 Recognise the importance of introducing research and
evaluation into practice.
Reader Information
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This annual report is comprised of eight main sections. Sections 4
to 7 are colour coded for ease of use.
 Section 1 is the introduction to the report and includes a
diagram signposting the readers to sections in the report
presenting research findings relevant to key Health,
Education, Criminal Justice and Social Policy aims. This
section also describes the methodology used to prepare
NCCDP briefing reviews.
 Section 2 summaries the methodology used in the briefing
reviews, upon which this report is based, and provides details
of the system used to grade the research evidence.
 Section 3 summaries the main review findings and key
gaps in research and practice to be addressed according to
the professional role for which they may be of most
relevance. Key research and evidence gaps are also presented
in terms of addressing national guidance and policy aims.
Sections 4 to 6 present a summary of evidence for the effectiveness
of different types of prevention models and interventions, for
example school, family, or community based approaches. Each
section represents a different level within the UK tiered system as
this is the approach that is most familiar to drugs professionals.
For a complete description of the tiered approach to treatment and
prevention please refer to Burrell et al., 2005.
 Section 4 covers Tier 1 services, which are universal and
targeted at all young people regardless of their level of risk.
This section will be of importance to a wide range of
professionals working across young people's services
[including schools, youth services and other community-
based services].
 Section 5 covers Tier 2 services, which are at the frontline of
specialist services. This section will be of importance to
professionals working in youth orientated services with
specialist youth knowledge and some knowledge of drugs
and alcohol [including workers from CAMHS, education,
voluntary youth services, social services, Connexions
Personal Advisors, accommodation providers, YOT youth
workers, counsellors and mentors].
 Section 6 covers services at Tiers 3 and 4, which are
considered together as tier 4 services are an adjunct to those
at tier 3. Tier 3 and 4 services are provided by specialist teams
to respond to the needs of young people who's tobacco,
alcohol and/or drug problems are significantly interfering
with other aspects of their life. This section will be of
importance to mental health, paediatric and child and
adolescent addiction specialists in addition to workers from
social services and the voluntary sector.
 Section 7 provides an introduction to health economics,
and describes some of the main drug prevention research
findings in this area. This section is of general interest and is
intended to give the reader an overview of some of the
methods used to evaluate drug prevention interventions and
programmes in terms of their value for money.This section is
adapted from a more comprehensive review to be published
by the NCCDP in 2006.
 Section 8 considers issues relevant to implementing
research evidence, such as is presented here, into practice.
Evidence-based practice reduces the reliance on intuition as
a basis for decision making and promotes the examination of
evidence from scientific and research literature as to 'what
works' in order to support best practice. This section will be
of interest to a wide range of professionals interested in
implementing drug prevention research evidence. For further
discussion please see Sumnall et al., 2006
How to use this report
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1.1 Self reported drug use in the young UK population
consistently exceeds that of many other European
countries [Hibell et al., 2004], and it has been estimated
that almost 3 million people in England and Wales
aged 16 to 24 have used illicit drugs in their lifetime
[Roe, 2005]. Younger age of drug initiation is associated
with a potentially greater number of years of ill health,
poorer academic performance, and a stronger likelihood
of progression into problematic patterns of use. An
increased understanding of the reasons why young
people use drugs, and the role that drugs play in their
lives, has meant that drugs can no longer be considered
in isolation. There is a strong relationship between drug
use and participation in other risky social and personal
behaviours and activities. The most successful prevention
interventions therefore provide generic and specific
support in response to dynamic biographies.
1.2 It has been argued [Bardo et al., 1996] that there are two
main types of theory to explain drug use in young people,
exposure and adaptive theories. Exposure theories
postulate that mere exposure to drugs of abuse is the
critical risk factor. This assumes that all humans are
biologically predisposed to the rewarding effects of drugs
and therefore all humans are at risk of becoming drug
users or drug dependent. Preventative strategies based
on this theory concentrate on demand and supply
reduction. Adaptive theories postulate that individual
differences [e.g. biological, social, familial] that existed
prior to drug exposure are the critical risk factors for
initiating drug abuse and developing problems with
drugs. Preventative strategies based on this theory
concentrate on reducing those individual and population
risk factors that might predispose towards drug use.
1.3 It is apparent that, regardless of particular vulnerabilities,
many young people choose to take drugs to fulfil specific,
often sophisticated, functions [Boys et al., 1999; Sumnall et
al., 2006]. On a behavioural level, rational drug choices
must maximise expected benefit from the outcomes
available and minimise the costs involved in doing so. For
example, young people may decide to use controlled drugs
because they have made a rational analysis of the positive
[e.g. pleasurable prosocial effects] and negative [e.g. health
risk] consequences of doing so [Gamma et al., 2005].
1.4 Rational choice models assume that the individual has
alternatives from which to choose [e.g. cocaine versus
sport], considers these alternatives at the same time,
understands the utility of each alternative [e.g. prosocial
and euphoric effects of cocaine, versus fitness and
prosocial effects of team sports], can quantify this utility,
and then assign a probability to this utility occurring
[e.g. “taking cocaine will definitely make me feel good”
versus “I'll need to practice a lot to become good at tennis
and start enjoying it”]. The introduction of biological
and social influences [c.f. adaptive and exposure theories]
further complicates the decision making process.
These include [Rhodes et al., 2003]:
 Parental education: there is some association between
parental education and adolescent substance misuse,
but this association is far from simple and the use of
cigarettes, alcohol, and cannabis ranges from being
significantly negative to being significantly positive.
Introduction
section 1
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 Family structure: a large body of research has found
that young people who reside with both biological
parents are less likely to be drug users. While this
research generally finds all types of substance misuse
to be more prevalent among young people who live
with a single parent, single parent homes are
sometimes associated with a variety of problem
behaviours and contextual factors.
 Economic situation: The economic status of the family
has generally not been found to be consistently
associated with young people's substance misuse.
In the US for example, substance misuse is often more
prevalent in affluent towns and neighbourhoods
[e.g. powdered cocaine], whilst in England, some
types of substance use are positively associated with
neighbourhood deprivation [e.g. crack cocaine].
 Parental style: Generally, the two extremes of over
protective and unsupportive, as well as poorly defined
and combative parental relationships can be
associated with drug use. Strong parental support and
monitoring has been found to be associated with less
substance use among young people.
 Sibling substance use: Substance use by siblings has
been argued to be amongst the strongest predictors
of problematic use. Merikangas and colleagues
[1992] reported that in first-degree relatives of opiate
dependent patients, 69% of siblings reported using at
least one illegal drug, and 63% met diagnostic
criteria for substance abuse. For all drugs, over 90%
of siblings who tried any illegal drug went on to
develop substance abuse.
 Personality and Psychology: experimentation and use
of illicit drugs need not indicate psychopathology,
but childhood disorders such as Attention Deficit
Hyperactivity Disorder [ADHD] and conduct disorder,
and personality traits such as impulsivity and sensation
seeking, are positively associated with drug use.
1.5 The likelihood of progression to problematic drug use
and dependence is closely related to patterns of
experimental drug use and the drugs used [Ridenour et
al., 2003]. Generally, there is a clear and often prolonged
progression from periods of experimental or irregular use
to dependence on drugs such as cannabis and alcohol
[taking place over the course of several years], but not for
crack cocaine and heroin, for which both tend to onset in
the same year. For individuals who go on to develop drug
dependency or problematic use, substance use disorders
[DSM IV criteria] are much more likely to have occurred
early in their drug using career.
1.6 Age of initiation and female status have also been shown
to be strong predictors of shorter latency times between
onset of use and dependence. Many additional factors
have been found to be associated with the progression
from experimental to more problematic drug use
[Hawkins et al., 1992], including; laws and norms
favourable towards drug use; availability of drugs;
extreme economic deprivation; neighbourhood
disorganisation; physiological characteristics; early and
persistent behavioural problems; family history of drug
use; poor family management practices; family conflict;
low bonding to family; academic failure; lack of
commitment to school; early peer rejection; social
influences to use drugs; alienation and rebelliousness;
and attitudes favourable to drug use.
1.7 Drug use has direct and indirect economic and social
costs, and problematic drug use can be a burden on
families and communities. Economic evaluation offers the
opportunity for planners of drug prevention policy and
services to be more efficient with, and to prioritise, the
finite resources available for implementation. However,
to date, the application of economic principles and
analysis in the drug prevention field has not been fully
exploited in the UK. In his review of the NHS, Wanless
[2004] highlighted the paucity of cost-effectiveness
evidence in public health generally. Economic thinking is
a recent innovation in drug policy and to date few good
economic evaluations of drug prevention strategies have
been undertaken, particularly in the UK.
1.8 Drug prevention is defined here as those interventions
that prevent the onset, delay the initiation, promote
cessation, and reduce the harms associated with drug
use. Drug prevention is a means of addressing a range
of health-related behaviours, and is a means of reducing
health inequalities and promoting social inclusion.
1.9 The NCCDP has published a series of briefings focusing
on recent government sponsored research, evaluation,
and policy related to drug prevention and treatment
among young people [defined as under 25 years old].
The purpose of this annual review is to build upon the
three previous briefings by presenting, categorising, and
grading research findings, and to present their relevance
to different professional groups. A discussion of some of
the challenges faced in implementing evidence-based
practice is also included [section 8].
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1.10 The briefings in this series are:
 Drug Prevention in vulnerable Young People.
 Tiered approach to Drug Prevention and treatment
among Young People.
 Universal Drug Prevention.
These are available electronically via the NCCDP website
[http://www.drugpreventionevidence.info/], or a limited
number of printed copies are available via the NCCDP
Information Service [see inside cover for contact details].
1.11 This report also includes an introduction to theories of
health economics, and describes some of the main drug
prevention research findings in this area. Health
economics is the branch of economics applied to health
and health care. It encompasses several distinct areas of
theoretical investigation, all of which may be applied to
drug prevention. For example, a service commissioner may
be presented with a choice of two prevention initiatives,
both of which are theory based and show evidence of
outcome effectiveness. By describing which approach
presents the best value for money, an economic evaluation
could help to prioritise resources. The NCCDP, in
collaboration with Dr Richard Fordham of the University
of East Anglia, has produced a full review of the health
economics of drug prevention [Fordham et al., 2006].
1.12 The findings here must all be considered within the
context of relevant policy [see figure 1]. Drug prevention
and treatment among young people is a key element of
the Updated Drug Strategy [Home Office, 2002]. In
addition, the 2004 Spending Review [HM Treasury, 2004]
Public Service Agreement [PSA] states that by 2008 there
should be a reduction of use of all Class A drugs and the
frequency of use of any illicit drugs among all young
people under the age of 25, especially by the most
vulnerable young people.
1.13 The Every Child Matters, Change for Children
programme aims to reform children's services, tackling
not only substance use but also the risk factors that may
promote it. 'Choose not to use Illegal Drugs' is part of the
'Be Healthy' objective. This work is closely linked to the
Updated Drug Strategy and will contribute to the target
above. The Every Child Matters Change for Children:
Young People and Drugs strategic guidance outlines
national expectations for local delivery of young people's
substance misuse services1:
 Children's and Young People's Plans - all areas
should produce a single, strategic, overarching 3  Year
plan for all local services to children and young
people. As referenced in section 17 of the Children's
Act. All areas are expected to agree joint drug targets
with Children's Services for 2005/2006. See
http://www.everychildmatters.gov.uk/strategy/planningand
commissioning/cypp/?asset=document&id=28094 sections
1.5, 1.14, 1.18, 1.27, 1.40, 2.5
 Duty to cooperate - statutory framework for local
cooperation between local authorities; key partner
agencies and other relevant bodies. The Children's
Act, reference section 10, requires local authorities
and their 'relevant partners' to cooperate to improve
children's wellbeing: defined as the five Every Child
Matters outcomes.
See:
http://www.everychildmatters.gov.uk/strategy/guidance/?a
sset=document&id=27964 sections 2.21, 2.64, Appendix 1
1.20, 2.48, 2.52, 2.53, 2.54
 Duty to safeguard / local safe guarding boards -
Section 11 of the Children Act 2004 placed a statutory
duty on key people and bodies to make arrangements
to safeguard and promote the welfare of children. This
duty took effect on 1 October 2005. Statutory
guidance was published in August 2005 and is
available from the following link:
http://www.everychildmatters.gov.uk/socialcare/safeguarding
/?asset=document&id=28266
1 See http://www.drugs.gov.uk/ReportsandPublications/YoungPeople/1111061244/ECM_YPD.pdf
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Figure 1.1:  Sections in the main report presenting research findings relevant to key Health,
Education, Criminal Justice and Social Policy
Updated Drugs Strategy 2002
Key YP target:  To reduce the use of Class A drugs and the frequent use of all illicit drugs by young people (<25 years old)
and in particular the most vulnerable, by 2008
EVERY CHILD MATTERS (2003/04)
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Sections
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5.39-40; 5.57; 6.1
Sections
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Sections
4.27; 4.35; 5.22; 5.26
Sections
4.2; 5.24-26; 5.27-32
Sections
5.42-46; 5.50-52; 5.58
Health Education Criminal Justice Social
CHOOSING HEALTH
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Little direct reference
to drug prevention,
but highlights the
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DRUGS GUIDANCE
FOR SCHOOLS (2004)
Reducing risk through
school engagement
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related needs and education
Responding to the social
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of young people
NATIONAL
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FOR JUVENILES IN
CUSTODY (2004)
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context of complete needs
Identification
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Increasing personal
health skills
Priority treatment access
Aftercare
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Actively manage the
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ANNUAL REVIEW OF DRUG PREVENTION: THE NATIONAL COLLABORATING CENTRE FOR DRUG PREVENTION10
 Common Assessment Framework (CAF) -
documentation is now available. All areas are
expected to implement CAF between 2006 - 2008.
A package of training and awareness raising materials
for local authorities are also available to use.
See:
http://www.everychildmatters.gov.uk/deliveringservices/caf
 A practical guide to multiagency working is available
from:
http://www.everychildmatters.gov.uk/deliveringservices/
multiagencyworking
1.14 Choosing Health and its associated delivery plan2, while
not specifically focusing on drug use, aims to reduce health
inequalities and improve the provision of information and
advice to vulnerable groups of young people.
1.15 Drugs: Guidance for schools3 makes recommendations
for schools on how to deal with drugs incidents, deliver
drugs education, identify drug use problems and respond
appropriately. The tiered model is used to place the work
of the school in a wider drug prevention context. The
need for a holistic approach is noted.
1.16 National specification for Substance Misuse for Juveniles
in Custody4 sets out the requirements of the Youth Justice
Board for the delivery of drug misuse interventions for
young people in custody. It was produced in response to
the Updated Drug Strategy aim to target action at the
most vulnerable young people, such as young offenders.
1.17 Transitions5 aims to identify how services can best support
16-25 year-olds with complex needs as they make the
transition to adulthood. It examines problems faced by
young people, sets out principles for effective services and
outlines government actions to be taken to improve
service delivery for young people with complex problems.
1.18 Whilst recognising that the evidence base is sparse, the
National Treatment Agency for Substance Misuse [NTA]
is developing a young people's strategy, and is likely to
include a briefing document on: 
 Care planning and retention; 
 Prescribing guidelines for community interventions
[in partnership with the Youth Justice Board for
England and Wales [YJB]]; 
 Guidance on assessing drug use; 
 The production of a directory of residential services
that work with substance misuse issues from both the
generic children's field and specialist substance
misuse services; 
 The identification of appropriate criteria for referring
a young person to residential care; and,
 The identification of different forms of service
provision that will enable Child and Adolescent
Mental Health Service [CAMHS] staff to contribute to
the substance misuse system6.
2 See http://www.dh.gov.uk/assetRoot/04/10/57/13/04105713.pdf
3 Available electronically from http://www.teachernet.gov.uk/
4 Available electronically from http://www.youth-justice-board.gov.uk/
Publications/Scripts/default.asp?eP=
5 See http://www.socialexclusion.gov.uk/downloaddoc.asp?id=785
6 At the time of writing these had yet to be published, please refer to the NTA
website for updates [http://www.nta.nhs.uk] 
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2.1 A full methodology, which has undergone peer review
by National Institute for Health and Clinical Excellence
[NICE] research specialists, is available upon request
from the NCCDP. The purpose of the briefing reviews
was to present evidence derived from Government
sponsored research in England and Wales to support
effective practice in drug prevention. The methodology
is summarised in Figure 2.1. The overall aim of this work
was to improve practice in the context of key
Government young people's policy.
2.2 In this report, the strength and robustness of prevention
approaches has been graded by NCCDP researcher
consensus according to criteria outlined in the
methodology. These ratings are included in the
summaries of research findings in sections 4 - 6.
For consistency and clarity it must be noted that only
key research themes were graded.
2.3 Briefly, the ratings are:
* Based on experience of best practice by health
professionals and expert groups (e.g. consensus,
nationally produced briefing/guidance documents).
** Only one medium quality study from the UK,
two or more studies with inconsistent findings
(on balance finding evidence of benefit or harm)
or studies of medium quality from outside the UK.
*** One good quality study or consistent findings in
two or more studies of medium quality carried out
within the UK and applicable to the target
population OR 2 or more good quality studies from
outside the UK but applicable to the target
population.
**** Consistent findings in two or more studies of good
quality carried out within the UK and applicable to
the target population.
An additional rating criteria was used, which signified
prevention approaches that warrant further research,
typically because they showed promise in smaller scale
research studies.
2.4 Findings based upon practitioner experience were those
for which there may not yet be a robust evidence base
but have been generated from the experiences of best
practice by health professionals and expert groups
[e.g. consensus groups, national briefing/guidance
documents]. Medium quality findings were defined as
being based upon well conducted, non-randomised
intervention studies [controlled non-randomised trial,
controlled before-and-after, interrupted time series],
comparative cohort and correlation studies with a low
to medium risk of confounding, bias or chance. Good
quality findings were defined as being based upon
well-conducted meta-analyses, systematic reviews of
randomised controlled trials [RCTs], or RCTs with a low
to medium risk of bias. Findings that did not fall under
these criteria were either excluded or only included as
contextual information.
Methodology
section 2
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Figure 2.1:  Diagrammatic summary of the methodology used to prepare NCCDP briefing reviews 
KEY GOVERNMENT POLICY AND GUIDANCEContext
What works in drug prevention?
Focus on Government Sponsored Research
and Evaluation in England and Wales (2000-2005)
Inclusion Criteria
Effectiveness of drug use
prevention research in
vulnerable young people;
Contemporary topics;
Primary study, review
or meta analysis
Data Extraction
Analysis of study characteristics
and quality;
Assessment of conclusions;
Interpretation of evidence;
Evidence gaps
Exclusion Criteria
Harm reduction in
established users;
Pharmaceutical
maintenance regimens;
General discussion papers not
specifying specific intervention
Research Question
Central
Government
departments and
agencies
Peer review
NCCDP
Grey literature
database
Specialist
libraries
Academic
literature
Sources of evidence
Comprising Academics;
Practitioners; Government
Research Specialists
Academic literature
provided supportive
theoretical and practical
evidence for data drawn
from Government
documents
Production
of Review &
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Sections 4 - 6 present research into the process, delivery,
and outcome of the main types of prevention approaches.
Please refer to these sections for descriptions of programme
characteristics and published outcomes. This section summarises
those findings according to the professional role for which they
may be of most relevance.
3.1 Executives, senior managers, commissioners and
budget holders
 Public health professionals [for example, Directors of
Public Health [DPH] and community development
staff].
 Policy and decision makers [for example, those
working in regional Government Offices, Strategic
Health Authorities [SHAs], the Drug Strategy
Directorate [DSD] and cross-governmental drug
misuse specialists].
 Commissioners and budget holders [for example,
members of primary care trusts [PCTs], drug [and
alcohol] action teams [D[A]ATs] chairs, and
managers, and joint commissioners working in local
authorities and the NHS.
 Children's trusts.
Key evidence for these professionals
 A variety of risk factors have been identified which
not only impact upon drug using behaviours, but also
key aspects of health development. It is therefore
important that drug use is placed within a broader
context of personal and social development, linked to
other related health, social, and educational issues.
 Generic interventions, bringing together different
professions and using multiple techniques target many
of those dimensions that also contribute to drug use.
 A greater emphasis should be placed on ensuring
effective training for specialist and generic workers.
 Family orientated programmes, with the aim of
developing parenting skills and supporting
improvements in the home environment, impact
upon a wide range of health and social behaviours.
 The mass media is the most frequent source of
information about drugs and responses to drugs.
Good media relations and a responsive media policy
has the potential to contribute to the development of
community based initiatives and to engage the
population in local services.
 School based social work and monitoring schemes
have been shown to have some effect on drug use
and attendance.
 The most effective prescribing services [tier 3 and 4]
may be those that integrate prescribing into existing
young person service provision.
3.2 Service providers
 Drug treatment services.
 Advocate groups.
 Tier 1 and 2 young people's substance misuse services.
 Resource developers.
 Counselling services.
 Youth Offending Teams [YOTs].
 Youth Offender Institutions [YOIs].
 Youth organisations.
 Social workers.
 Leaving care teams.
Main review findings
section 3
Key evidence for these professionals
 Drug use must be considered in the context of other
vulnerabilities such as disengagement from school;
lack of skills; unemployment; not living with parents;
long term illness; living in homes where there is drug
use by others; and developmental and behavioural
disorders.
 Vulnerable groups of young people tend to report
higher prevalence and frequency of drug use, and
earlier ages of initiation.
 Targeted interventions should also specialise within
target groups where there will be different levels of
need and responsiveness.
 The key to successful recruitment of young people
and their parents and families appears to be via those
networks with school and community to which a
service is most strongly linked. Target families with
positive service experiences are also useful sources of
further recruitment. Retention is enhanced by
involvement of children or provision of meals,
transportation and childcare.
 Less structured work, although still theory based,
is often the most productive in working with
young people.
 There is a limited amount of evidence to suggest that
brief interventions may sucessfully help young people
to moderate their drug use.
 Moderately intensive family-based interventions can
have a positive effect upon a wide range of outcomes,
including drug use, problem behaviours, educational
engagement, and offending.
 Community mobilisation [projects which aim to help
people feel more positive about community strengths
and their potential to tackle problems caused by
drugs], whilst a promising technique requires
considerable strategic coordination. Such approaches
have to look beyond the more obvious routes of youth
services and schools, [e.g. media, business, and
entertainment/cultural providers].
 Approaches in nightlife settings should promote
healthy lifestyles in addition to consideration of
drug use.
 Pharmacological interventions [at tier 3 and 4] should
only be used after consideration of all risk factors, and
in conjunction with other types of therapy.
3.3 Community-based professionals
 Healthcare professionals [for example, general
practitioners, practice nurses, health promoters].
 Education specialists [for example, teachers in
mainstream education and working with excludees]
and school drugs officers.
 Community organisations.
 Youth groups.
Key evidence for these professionals
 Delivery of universal prevention is optimal before the
transition period in mid adolescence [11-14 years old]
as there is a greater attachment to family and
educators than peers.
 Community based truancy interventions have
significant effects upon psychosocial factors that
subsequently modulate drug use.
 Schools play an important role in the delivery of
universal drug interventions as they offer an efficient
means of targeting a large number of people and
have been identified as an important protective factor
against drug use and social exclusion.
 The greatest barriers to school based interventions are
poor implementation and dissemination.
 There is fairly good evidence to support interventions
based on life skills approaches, normative education,
commitment not to use drugs, and intentions not to use.
 There is often little consideration of non drug-related
outcomes in prevention projects [e.g. health].
 Interventions that aim to improve the school
environment make a positive contribution to reducing
drug use.
 Healthcare professionals are ideally placed to contribute
to family and community based interventions.
 Interventions preventing and delaying pregnancy in
drug using young women, will reduce the likelihood
of the foetus and infant being exposed to the harmful
effects of drugs and drug use.
 Parenting in the context of problematic drug use
places children at increased risk of physical harm and
negative social and developmental outcomes.
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3.4 Academics, designers, planners and evaluators of
drug prevention projects
 Health professionals and drugs experts based in
universities, government departments, D[A]ATs,
PCTs, LEAs and SHAs.
Key evidence for these professionals
 In general, there is a poor culture of evaluation and
research in the UK relating to drug prevention.
 There has been little work performed addressing the
prevention needs of primary school aged children.
Effective, theory based interventions need to be
developed and evaluated.
 There is emerging, but promising, US based work on
the effectiveness of strategies targeted at the years
prior to birth, infancy, and childhood.
 The development of screening tools aimed at
identifying those young people most at risk from drug
use is required. These might include prodromes of
problematic behaviour, personality traits, risk taking
behaviours, attitudes to drug use and education.
3.5 Key gaps in research and practice
Based upon the literature sources and NCCDP reviewer
consensus, important gaps in the research and practice
evidence, which require further investigation, have been
described. The whole field would benefit from the long
term, longitudinal, outcome evaluation of drug
prevention projects, something which is currently lacking.
Table 3.1 describes key general gaps in particular
prevention approaches according to professional role,
and Table 3.2 extends this and considers gaps at different
tiers. Table 3.3 presents key gaps in the context of
Choosing Health; Drugs: Guidance for Schools;
Every Child Matters; National Specification for Substance
Misusers; and Transitions. The ordering of gaps does not
represent perceived priorities.
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Table 3.1: Gaps to be addressed by key professional groups across the tiered model. These have
been chosen on the basis of the research reviews presented in sections 4 - 6, and are not intended to
be exclusive.
GAP
RESEARCH
AND
EVALUATION
LONG-TERM
SUCCESS OF
UK-BASED DRUG
PREVENTION
APPROACHES
MULTI-AGENCY
WORKING
TIERED MODEL
OF DRUG
PREVENTION
COMMUNITY-
BASED
PROGRAMMES
PARENT DRUG
EDUCATION
PROGRAMMES
EXECUTIVES, SENIOR
MANAGERS,
COMMISSIONERS AND
BUDGET HOLDERS
Allocation of resources to
support development of
pilots for new or innovative,
evidence based interventions,
through effective working of
Local Strategic Partnership.
As above.
Independent monitoring of
multi-agency working.
Commissioning of needs
assessment and health
impact assessments to
determine intervention
needs across the four-tiered
model for local populations.
Allocation of resources to
support development of
pilots for new or innovative,
evidence based universal and
targeted drug education
programmes based in the
community.
Allocation of resources to
support development of
pilots for new or innovative,
evidence based universal
and targeted drug education
programmes for parents
and carers.
SERVICE PROVIDERS
Working at all levels to
disseminate intervention and
research outcomes through a
variety of media and
presentation techniques.
Approaching research and
evaluation [process, fidelity
and outcome] as a means of
improving practice, and fully
integrating the evaluation
from the intervention's
conception.
Monitoring sources of referral,
and appropriate use and
quality of external providers.
Maintaining an awareness
of individual and group
barriers to engagement with
services and supporting
young people in identifying,
managing, and resolving
risky [drug related]
behaviours.
Approaching research and
evaluation [process, fidelity
and outcome] as a means of
improving practice, and fully
integrating the evaluation
from the intervention's
conception.
ACADEMICS,
DESIGNERS, PLANNERS,
EVALUATORS
General need for improved
research and evaluation, and
to foster a culture of
research, particularly with
regard to tiers 2 to 4.
Undertake long-term
research [>2 years] using
robust outcome measures
[e.g. reduction in drug use]
of most approaches in the
UK, particularly of drug
prevention interventions
for vulnerable young people
and harm reduction
interventions for problematic
young drug users.
Effectiveness of inter-agency
and cross departmental
working.
Undertake research to
establish the relative
effectiveness and cost-
effectiveness of different
approaches between and
within the different levels
of the tiered model.
Further research into the
effectiveness of drug
education delivered to young
people in the community.
Considering the relative
effectiveness of universal and
targeted programmes.
Further investigation of
effective means of engaging
and retaining parents and
carers in drug education
programmes.
Further evaluation of UK-
based drug education
programmes for parents and
carers including the relative
effectiveness of targeted and
universal approaches.
COMMUNITY BASED
PROFESSIONALS
Assessment of needs,
resources and capacity to
develop and deliver
community based drug
prevention programmes.
Assessment of needs,
resources and capacity to
develop and deliver
prevention programmes
across the four-tiered model
for local populations.
Engaging communities in
the development of
community based drug
prevention programs
through health promotion,
health education, awareness
raising and other community
development activities.
Engaging communities in
development of community
based drug prevention
programs through health
promotion, health education,
awareness raising and other
community development
activities.
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Table 3.2: Gaps to be addressed by key professional groups across Tiers 1 to 4. These have been
chosen on the basis of the research reviews presented in sections 4 - 6, and are not intended to be
exclusive.
GAP EXECUTIVES, SENIOR
MANAGERS,
COMMISSIONERS AND
BUDGET HOLDERS
SERVICE PROVIDERS ACADEMICS,
DESIGNERS, PLANNERS,
EVALUATORS
COMMUNITY BASED
PROFESSIONALS
Effectiveness of multi-
component programmes and
the relative effectiveness of
individual components.
Undertake further evaluation
of the effectiveness of different
approaches for the delivery of
drug education to primary
school aged children. Focusing
on the recommendations in
Section 3.
Further investigation of
interventions that provide
continuity during the transition
period between primary and
secondary school.
Further evaluation of
effective ways of supporting
schools to implement
evidence-based, effective
school drug policies.
Further evaluation of the
effectiveness and cost-
effectiveness of mass media
and social marketing
campaigns.
Further research into the
impact of generic and early
years interventions (targeting
broader themes such as
social inclusion and health)
on drug use.
Undertake longitudinal
research on the impact
of diversionary/inclusion
interventions (e.g. Positive
Futures) on drug use and
other related social and
health behaviours.
continued.....
Assessment of needs,
resources and capacity to
develop and deliver multi-
component drug prevention
programmes as a whole and
as individual components.
Maintaining an awareness of
the vulnerabilities that
children may face during the
transition period between
primary and secondary school.
Assessment of needs,
resources and capacity to
develop, deliver and support
the implementation of
evidence-based, effective
school drug policies.
Assessment of needs,
resources and capacity to
develop and deliver
appropriate diversionary and
inclusion programmes.
Approaching research and
evaluation (process, fidelity
and outcome) as a means of
improving practice, and fully
integrating the evaluation
from the intervention's
conception.
Approaching research and
evaluation (process, fidelity
and outcome) as a means of
improving practice, and fully
integrating the evaluation
from the intervention's
conception.
Considering drug use within
the broader context of young
people's biographies (generic
health, social, and education
improvements may be more
important than specific
health outcomes).
Approaching research and
evaluation (process, fidelity
and outcome) as a means of
improving practice, and fully
integrating the evaluation
from the intervention's
conception.
Allocation of resources and
development of local
implementation strategies to
support pilot community-
based multi-component
('holistic'), prevention
programmes for young
people through effective
working of Local Strategic
Partnerships.
Allocation of resources to
support development of
pilots for new or innovative,
evidence based interventions
for the delivery of drug
prevention to primary
school-aged children.
Allocation of resources to
support development and
implementation of effective,
evidence-based drug policies
in schools.
Allocation of resources to
support development of
pilots for new or innovative,
evidence based mass media
and social marketing
campaigns.
Allocation of resources to
support development of
pilots for new or innovative,
evidence based diversionary/
inclusion programmes.
TIER 1
MULTI-
COMPONENT
UNIVERSAL
DRUG
PREVENTION
PROGRAMMES
PRIMARY
SCHOOL BASED
DRUG
PREVENTION
TRANSITION
BETWEEN
PRIMARY AND
SECONDARY
SCHOOL
DEVELOPMENT
AND
IMPLEMENTATION
OF SCHOOL DRUG
POLICIES
MASS MEDIA
AND SOCIAL
MARKETING
CAMPAIGNS
GENERIC AND
EARLY YEARS
INTERVENTIONS
TIER 2
DIVERSIONARY/
INCLUSION
PROGRAMMES
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EARLY
INTERVENTION
FOR HIGH RISK
YOUTH
TRUANTS AND
SCHOOL
EXCLUDEES
YOUNG
OFFENDERS
LOOKED AFTER
CHILDREN AND
CARE LEAVERS
CHILDREN IN
DRUG USING
FAMILIES
BME
POPULATIONS
GAP EXECUTIVES, SENIOR
MANAGERS,
COMMISSIONERS AND
BUDGET HOLDERS
SERVICE PROVIDERS ACADEMICS,
DESIGNERS, PLANNERS,
EVALUATORS
COMMUNITY BASED
PROFESSIONALS
Commissioning of needs
assessment to determine
intervention needs for local
populations of young people
with early onset drug use.
Commissioning of needs
assessment to determine
intervention needs for local
populations of truants and
excludees.
Commissioning of needs
assessment and health
impact assessments to
determine intervention
needs for local populations
of young offenders.
Allocation of resources to
support development of
pilots for new or innovative,
evidence based programmes
for drug-using parents and
their children.
Commissioning of needs
assessment and health
impact assessments to
determine intervention
needs for local populations
of children in drug using
families.
Commissioning of needs
assessment and health
impact assessments to
determine intervention
needs for BME communities.
Becoming active participants
in training and professional
development in order to
address the need for
standardised drug education
for those caring for young
people in residential units and
foster care. There is a need for
focus on transferable skills.
Mainstream statutory services
need to investigate whether
current interventions and
services, which may have only
been evaluated in small
populations, would be
effective in the wider
population of drug using
families.
Need for capacity building
within BME communities
alongside the development of
local partnerships to deliver
culturally appropriate services,
including the delivery of drug
prevention services within
wider non-specialist services
(e.g. GP surgeries).
Maintaining an awareness
of the high-risk behaviours
that may indicate future
problematic drug use in a
young person (e.g. educational
underachievement, sensation
seeking, risk taking).
Assessment of needs,
resources and capacity to
develop and deliver
appropriate services (e.g.
alternative education
provision, access to
employment) for school
excludees.
Assessment of needs,
resources and capacity to
develop and deliver
appropriate services for
young offenders.
Identification of training needs
and delivery of training
programmes for the
development of standardised
drug education for those caring
for young people in residential
units and foster care.
Maintaining an awareness of
the challenges that care
leavers may face.
Assessment of needs,
resources and capacity to
develop and deliver
appropriate services for
drug-using parents and their
children.
Engaging BME communities
in the development of
community based culturally
appropriate drug prevention
programmes through health
promotion, health education,
awareness raising and other
community development
activities.
Undertake further research
into effective interventions
for young people with early
onset drug use.
Evaluation of drug education
provision for school
excludees and the transition
to alternative education
provision, including long
term strategic approaches to
absenteeism and exclusion.
Further research into the
needs of young offenders.
Consideration of appropriate
drug treatment interventions
and other behavioural and
social interventions.
Further research into the
provision of standardised
drug education (including
VSA) for those caring for
young people in residential
units and foster care.
Undertake further research
on the effectiveness of
services supporting families
and carers of problematic
drug users. Consider the
transferability of US and
Australian-based
programmes.
Investigate the needs of
drug-using parents in terms
of treatment and support.
Further investigation of the
effectiveness of BME
targeted drug prevention
programmes e.g. prevention
effects of programmes with
cultural components.
continued.....
ANNUAL REVIEW OF DRUG PREVENTION: THE NATIONAL COLLABORATING CENTRE FOR DRUG PREVENTION 19
TIERS 3 AND 4
TIER 3 AND 4
INTERVENTIONS
Allocation of resources to
support development of
pilots for new or innovative,
evidence based interventions
at tiers 3 and 4, through
effective working of Local
Strategic Partnership.
Commissioning of needs
assessment and health
impact assessments to
determine intervention
needs for local populations
of children in drug using
families.
Approaching research and
evaluation (process, fidelity
and outcome) as a means of
improving practice, and fully
integrating the evaluation
from the intervention's
conception.
Undertake evaluation of the
effectiveness of interventions
and approaches at tiers 3 and
4, particularly with regards to:
 Needs of young people
referred to tier 4 services;
 Effectiveness of harm
reduction strategies in
reducing risk-taking
behaviour.
 Pharmacological
management of drug
dependence.
 Factors determining
successful retention,
outcomes and relapse
prevention.
 Relative effectiveness of
pharmacological agents
for the management of
uncomplicated
detoxification.
 Effective models of care
at tier 4 e.g. residential
versus foster care
placements.
Assessment of needs,
resources and capacity to
develop and deliver
appropriate tier 3 and 4
services.
GAP EXECUTIVES, SENIOR
MANAGERS,
COMMISSIONERS AND
BUDGET HOLDERS
SERVICE PROVIDERS ACADEMICS,
DESIGNERS, PLANNERS,
EVALUATORS
COMMUNITY BASED
PROFESSIONALS
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TABLE
Table 3.3: Key research and evidence gaps, which if addressed, would help to support and achieve
the aims of national guidance and policy. These have been chosen on the basis of the research
reviews presented in sections 4 - 6, and are not intended to be exclusive.
CHOOSING HEALTH
DRUGS: GUIDANCE
FOR SCHOOLS
NATIONAL
SPECIFICATION FOR
SUBSTANCE MISUSERS
FOR JUVENILES IN
CUSTODY
TRANSITIONS
EVERY CHILD
MATTERS
 Understanding how clusters of risk factors lead to an increase in individual vulnerabilities to poor health
and increase health inequalities.
 Exploration of how drug use is perceived as a stigmatising factor in marginalised groups and how this
may prevent young people from seeking help for a broad range of health related problems.
 Understanding how strengthening of generic protective factors leads to protection against a variety of
risky behaviours.
 Understanding how resilience to drug use in some young people raised in environments of social and
health inequality relates to personal, psychological, and emotional factors. Understanding the importance
of healthy behavioural choices in these young peoples' lives when balanced against all other available
behavioural choices.
 Longitudinal research on the impact of intervention approaches such as diversionary/social inclusion
projects, self efficacy strategies, parenting skills, on healthy lifestyles.
 An examination of the effectiveness of current drug related curricula in school, and the skills needs of
teachers tasked to deliver it.
 Investigation of how drug use becomes a barrier to school attendance and re-engagement.
 Examination of how exclusion may lead to an escalation of drug use, with particular respect to prevalence
and causation.
 Strategies to improve the whole school environment and how this affects risk factors such as educational
aspiration, truancy and absenteeism, and parental engagement.
 How transition to alternative education provision and/or employment affects drug use and behaviour.
 Description and effectiveness of long term strategic approaches to absenteeism and exclusion.
 Investigation of the effectiveness of [early] family and social interventions upon offending behaviour.
 Further surveys on drug use in young offender populations, including additional analyses that allow a
greater understanding of differences in drug use on the basis of sex and ethnicity.
 Examination of the initiation of drug use in young offenders after they have entered the criminal justice
system, and effective responses to such uses.
 Examination of models of multi-agency working and the development of toolkits to assist local strategies.
 Optimum transition stage between youth and adult services.
 Examination of changes in drug using behaviours, and support pathways in those leaving youth services.
 Service provision for marginalised groups within the care system should be explored, and research
conducted into effectiveness and appropriateness.
 Research is needed into the most appropriate way of incorporating drug prevention interventions within
broader programmes targeted towards this population.
 Specific gaps for previous policies are relevant.
 Modelling of drug using careers.
 Development of tools for assessing drug use within young people's services.
 Longitudinal evaluation of youth orientated projects on a range of health behaviours, including drug use.
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Tier 1
Tier 1 services are universal drug education and interventions targeted at all young people, regardless of their level of
risk. Any professional group in contact with young people delivers tier 1 services; specialist knowledge about drugs is
not necessarily needed.
Effectiveness shown but more effective in
those at low risk. Programmes based on life
skills show most consistent effects.
Should focus upon family intervention and
parent education, and school organisation
and behavioural management.
Findings are mixed.
Little UK research has been undertaken.
Lack of research evaluating universal
approaches.
Standalone interventions are not effective. 
Some evidence for effectiveness based on
related factors.
School-based drug
prevention [aged 11+]
Primary school-based
drug prevention
Peer education
Family intervention
Community-based drug
prevention
Mass media
Parent education

 
 
 
 
 
 
warrants further research;  * based on practitioner experience [i.e. good practice];  ** medium quality finding;  *** medium to good quality finding;
**** consistent, good quality finding.
Intervention Evidence Grading Nature of evidence
* ** *** ****
Interventions
section 4
SCHOOL-BASED UNIVERSAL PREVENTION
PROGRAMMES
Understanding drug use
4.1 Recent surveys of drug use indicate that approximately
18% of pupils [aged 11 to 15 years] have taken drugs
within the last year and 10% within the last month
[Department of Health, 2005], highlighting the need for
ongoing drug prevention initiatives for young people.
4.2 Schools have an important role to play in the delivery of
drug education as they offer an efficient means of
targeting a large number of young people and have been
identified as an important protective factor against drug
use [Lloyd et al., 2000].
Effective practice
4.3 Review level evidence has identified that school-based
intervention programmes aimed at young people can
delay the onset of substance use by non-users for a short
time, and temporarily reduce use by some current users
[Canning et al., 2004; McGrath et al., 2006]. School or
curricular-based drug prevention appears to be more
effective in lower-risk young people than those at higher
risk, which may have implications for cost-effectiveness.
4.4 Life Skills Training [LST], or approaches based upon it, is
one of the few programmes that has demonstrated a
small but positive effect on reducing indicators of drug
use. However, it should be noted that the programme is
only effective when fidelity and completeness of delivery
are high, and that the longevity of the effect may also be
questionable [Coggans et al., 2003].
4.5 A recent systematic review published by the Cochrane
Collaboration [Faggiano et al., 2005] found that
programmes based on life skills were the most consistent
at reducing some aspects of drug use in school settings,
indicating that there is fairly good evidence to support
drug programmes based on the social influence model.
Normative education, students' commitment not to use
drugs and intention not to use drugs are also reported to
be important mediators of drug use [Cuijpers, 2002a, b].
4.6 There is weak evidence to support the finding that
effective programmes tend to include booster sessions
[White and Pitts, 1998]. For example, most of the
programmes found to have a positive impact on cannabis
use had booster sessions [or similar extra components]
that aimed to reinforce the effects of the programme
[Skara and Sussman, 2003].
4.7 Based on weak evidence, school-based programmes may
be more effective when they are delivered to pupils
between the ages of 11 to 14 years [Gottfredson and
Wilson, 2003]. Therefore, it may be suggested that
delivering prevention programmes to primary school
pupils does not have long-term positive effects that
outweigh the benefit of providing such programmes to
middle/high school students.
4.8 There is no convincing evidence to indicate that intensive
programmes are more effective than non-intensive
programmes [Gottfredson and Wilson, 2003; White and
Pitts, 1998].
4.9 There is little supportive evidence for the effectiveness of
primary school based prevention [i.e. children aged 5-10
years]. However, this may largely be due to the lack of
pertinent research in this area, and social attitudes
opposing drug education in young children. Evaluation
suggests that primary school education that focuses upon
knowledge, attitudes, and values has limited benefit
[Godfrey et al., 2002]. Review of the limited literature
available suggests that primary school interventions
should focus upon family intervention and parent
education, and school organisation and behavioural
management [Lloyd et al., 2000; Toumbourou et al., 2005].
4.10 Compared to the US, where the majority of the research
evidence originates from, the effectiveness of different
elements within multi-componented programmes have
not been sufficiently examined in the UK. Due to the
poor methodology of the studies that have examined
multi-component programmes there is little evidence
that combining 'social environment change' [such as
parent training, mass media and community-wide
programmes] with school-based interventions is more
effective than delivering school-based interventions
alone [Flay, 2000].
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4.11 Findings are mixed with regard to the effectiveness of
peer-led education [Canning et al., 2004; McGrath et al.,
2006a; McGrath et al., 2006b]. It appears that the child or
young person delivering the intervention tends to benefit
most from the experience. Based on results from
one meta-analysis [Cuijpers, 2002b] the use of peer
educators was found to be an effective characteristic of
multi-component programmes that had 'strong evidence'
of effectiveness. However, this positive effect only seems
to be supplementary. Evidence suggests that peer
educators can only help increase the effectiveness of an
already successful programme, and that the effect may
be relatively short-lived.
4.12 Drama or theatre has been used in the UK as a method
for drug prevention and education, and during the 1990s
was promoted as an innovative approach to drug
education. Whilst there is a lack of evidence regarding
the efficacy of such methods in changing health-related
behaviour, there is some evidence to suggest that they
may appear to be more effective at changing attitudes to
drug use than traditional information dissemination
approaches [Canning et al., 2004; McGrath et al, 2006a].
4.13 There is a lack of research evaluating the effectiveness of
primary prevention interventions, such as the
introduction of random drug testing in schools [reviewed
by McKeganey, 2005]. The introduction of such
programmes raises a wide range of concerns including
undermining of trust between staff and pupils. A large
scale national study of the rates of drug use in the US,
comparing schools with and without testing, showed
no difference in reported prevalence, indicating that the
intervention was not responsible for reducing drug use
[Yamaguchi et al., 2003].
Delivery
4.14 Interactive approaches to drug education [e.g. role-play]
are more effective than non-interactive approaches
[e.g. a lecture] [Faggiano et al., 2005]. According to one
meta-analysis [Tobler et al., 2000] there was 'strong
evidence' to suggest that interactive methods of
delivering drug prevention interventions were more
effective than non-interactive methods in reducing
drug use.
4.15 Research undertaken in the US indicated that although
schools were implementing evidence-based, effective
school programmes the quality of implementation was
often low because of lack of teacher training, lack of
materials and the failure to deliver lessons to age
appropriate groups [Hallfors and Godette, 2002].
4.16 Schools need support to enable them to develop and
implement effective drug policies and education.
Approved community-based agencies may usefully
support schools and successful implementation may be
linked to the whole school viewing drug education as a
priority [Evans et al., 2001].
4.17 An emphasis should be placed on ensuring effective
teacher training as drug education is more effective when
taught by teachers who have acquired the necessary
subject knowledge.
FAMILY-BASED UNIVERSAL PREVENTION
PROGRAMMES
Understanding drug use
4.18 Family factors play an important role in young people's
choices around drug use. For example, a cohesive family
unit and high parental supervision have both been
shown to be protective against drug use [Best and Witton,
2001]. Research on the effects of parenting styles has
frequently distinguished between parental support,
monitoring, and rule-setting. In general, strong parental
support and monitoring has been found to be associated
with less drug use. In contrast, studies of parental
rule-setting have either found no such association,
or a positive association. Generally, the two extremes of
over-protective and unsupportive, as well as poorly
defined and combative parental relationships can be
associated with drug use.
4.19 Serious difficulties have been found in recruiting and
retaining families in drug prevention programmes
[Velleman et al., 2000].
Effective practice
4.20 Canning and colleagues [2004] found that British parent-
orientated programmes have not been adequately
evaluated. There is an indication that such programmes
may be poorly attended, particularly among parents who
drink and smoke more heavily.
4.21 Following evaluation of five drug prevention programmes
for parents,Velleman and colleagues [2000] found that the
key to successful recruitment of parents appeared to be
the networks within the school or community to which a
project was most strongly linked. Following engagement
in these programmes parents reported that they were
more knowledgeable about licit and illicit drugs, and felt
more able to communicate with their children about
drugs. Parents also reported an impact in terms of more
broad support including increases in self-confidence, and
in general communication and parenting skills.
4.22 Behavioural parent training, family skills training and
family therapy have been identified as effective family
strengthening interventions [Kumpher and Alvarado,
2003], although it is unknown whether they are
significantly more effective other types of approaches.
4.23 Examples from the international literature demonstrate
that there is early evidence that moderately intensive
family-based interventions can reduce risk factors for
drug use in children. For example, The Strengthening
Families Program For Parents and Youth was aimed at
10-14 year olds, and provided guidance to parents on
family management skills, communication, academic
support, and parent-child relationships [Spoth et al.,
2002]. Evaluation found delayed initiation of alcohol
and cannabis use at six-years follow up. Other findings
showed improved youth resistance to peer pressure to
use alcohol, reduced affiliation with anti-social peers,
and reduced levels of problem behaviours.
4.24 There are promising indications in the international
literature that parent education programmes may impact
on cannabis use and may be a potentially useful strategy
to assist families facing a high number of risk factors for
harmful adolescent drug use [Loxley et al., 2004].
Delivery
4.25 Evidence from the US indicates that interactive
approaches are a more effective method for delivering
family focused interventions [Kumpher and Alvarado,
2003]. Programmes delivered in an interactive manner
were well received, particularly by parents with low
socio-economic status.
COMMUNITY-BASED UNIVERSAL PREVENTION
PROGRAMMES [INCLUDING MASS MEDIA
INTERVENTIONS]
Understanding drug use
4.26 Community-based interventions may be described as a
combined set of activities organised in a specific region or
town, aimed at adolescents, as well as parents and other
people and organisations [Burkhart and Matt, 2003].
However there is a lack of a uniform concept of the term.
4.27 An important role for businesses was identified as part
of the Updated Drug Strategy [2002], maximising the
potential of the workplace as a setting for awareness
raising, education and support for employees through
the introduction of drug and alcohol policies and the
distribution of information.
4.28 The media is the most frequent source of drugs
information for young people. The most appropriate
roles for media communications campaigns are raising
awareness of messages and interventions, and
encouraging attitudinal change. Television could be a
useful medium through which to communicate with
young people, as they are heavy media consumers,
particularly of mainstream television shows [Stead et al.,
2002]. However, research from the US, where mass media
campaigns are long established have shown
mixed results, and whilst parents received them
favourably, they have no distinguishable effects on
youth [drug-related] behaviour.
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Effective practice
4.29 Community interventions have been commonly
delivered in combination with other drug prevention
initiatives such as those based in schools. While there is
evidence that additional components, including
community-wide programmes, can be effective, there is
little evidence of the added effects of these approaches
over and above the school-based programmes [Flay,
2000]. Few studies have been able to separate the added
effects of community interventions, and of those that
have, the findings are inconclusive.
4.30 The international literature demonstrates that although
community mobilisation may require considerable
coordination, there is some evidence in favour of this
type of strategy [Loxley et al., 2004]. In a small-scale study
in the UK, Smith [2001] found that consulting and
engaging the community helped people to feel more
positive about the strengths of their community and its
potential to tackle problems caused by drugs. The
research identified that communities may have to be
creative in building effective partnerships, such as
looking beyond the 'obvious routes of youth services
[and] schools', in order to deliver drug prevention
activities.
4.31 Currently, youth work practice does not appear to be a
particularly appropriate setting for universal drug
prevention, especially in young children. A survey of drug
education policies and practice in the youth service in
England found that provision of drug education was
diverse and that there were a number of different models
of intervention [Drugscope, 2003]. Most services were
addressing drug issues at tier 1 and 2. 'Holistic'
programmes, using an interactive approach and combining
health and lifestyle elements with drug issues, may be the
most appropriate method of drugs prevention education in
youth work practice [Ward and Rhodes, 2001].
4.32 The working environments of some youth workers and
the responsive nature of youth work have proved to be
barriers to the implementation of projects in youth work
settings [Shaw, 2001]. Ward and Rhodes [2001] identified
that project workers felt it was inappropriate to place too
much emphasis on drug use and, in particular, schools
were identified as a more appropriate setting for drugs
education in younger children [8-12 years].
4.33 Universal drug prevention initiatives are unlikely to be an
effective means of delivering drug education to the
majority of those participating in the nightlife
environment, as drug use is already likely to be high
[Deeham and Saville, 2003]. However, universal initiatives
may potentially exert effects on younger individuals, new
to the nightlife environment and contemplating taking
drugs for the first time.
4.34 Universal approaches in the nightlife environment
should promote consideration of health related
behaviours surrounding drug use and lifestyle
[Panagopoulos and Ricciardellis, 2005]. Environmental
variables play an important role in drug-related harm and
so need to be regulated and monitored. There is also the
potential to provide accurate information on safer drug
use [Webster et al., 2002], although, as with other
information-based approaches, there is no evidence that
this approach influences behaviour.
4.35 Drug testing in the workplace has not been shown to be
an effective deterrent against drug use [Independent
Inquiry into Drug Testing at Work, 2004], which largely
takes place outside the work environment. Work-based
prevention initiatives could potentially stress the impact
of acute and sub-acute drug [and alcohol] intoxication
upon performance and safety.
4.36 Media interventions have not been shown to be effective
in preventing drug use if they are used as a stand-alone
intervention [McGrath et al., 2006b]. Evaluation of the US
National Youth Anti-drug media campaign [launched in
1997 and primarily targeting 10 year olds] found that
although the campaign had a favourable effect on
parents, it was not effective in preventing drug use, or
changing beliefs or attitudes in young people [Hornik et
al., 2003].
4.37 Media advocacy has the potential to contribute to
community-level drug prevention initiatives and to
actively engage young people in local and community-
based projects. In addition, media can be a useful method
to raise an intervention or agency profile, and assist in
securing support from key stakeholders and investors
[Eadie et al., 2002].
Delivery
4.38 In a meta-analysis that examined the relative
effectiveness of different media sources in the US
[Derzon and Lipsey, 2002], messages communicated via
video were associated with the largest positive effect on
three drug related outcomes, behaviour, attitudes and
knowledge. In addition, supplementing the media
message with other components [such as group
discussion, role play or supportive services] was
associated with a positive effect on these outcomes.
GENERIC UNIVERSAL PREVENTION
PROGRAMMES
Understanding drug use
4.39 Factors associated with both a greater and a reduced
potential for drug use have been identified and these may
impact on the psychological and social development of
young people [Best and Witton, 2001]. Many of these risk
factors also predict other adolescent problem behaviours
and it is important that the delivery of drug prevention is
set within a broader context of personal and social
development, linking to other related health, social and
educational issues.
4.40 A number of prevention strategies may target drug use as
one component within a broader set of prevention goals,
they may target drug use explicitly or contribute to the
reduction of drug use by addressing common
developmental determinants [Loxley et al., 2004].
Effective practice
4.41 Research evidence is limited, but US evaluation of
universal interventions targeted at years prior to birth,
infancy and childhood have shown some promise
[reviewed by Loxley et al., 2004].
4.42 Sure Start is a government programme supporting
children and their families from birth up to age 14 [up to
age 16 for children with special needs or disabilities].
The programme aims to increase the supply of good
quality early learning, childcare and health, and family
support, as well as encouraging the development of
integrated and joined up services. Early evaluation of the
programme indicated that when variation within Sure
Start Local Programmes [SSLP] and comparison areas
was considered, SSLP areas were more than twice as
likely to show evidence of better-than-expected
functioning across multiple outcomes related to child
development and parenting [National Evaluation of Sure
Start, 2004].
4.43 Universal services may play an important role in
identifying mothers with substance-related needs and/or
drug-exposed children through screening and
assessment. Small-scale studies have shown that
pregnant women accept screening and assessment, but
that no behavioural outcomes have yet been established
[Loxely et al., 2004].
4.44 The international literature demonstrates a promising
role for family home visiting in reducing family-level risk
factors for drug abuse [Loxley et al., 2004]. However,
intensive home visits are only cost effective when
provided as a selective or indicated intervention, and may
provide no benefit when applied universally.
4.45 The international literature demonstrates the value of
childhood parent education programmes for tackling
child behaviour difficulties [Loxley et al., 2004].
A systematic review of parent education programmes in
children aged 0 to 4 years showed that these programmes
have moderate effects, with short-term improvements
observed in two thirds of participants [Mitchell et al.,
2001]. These programmes focused on developing strong
bonds between parents [generally mother] and child,
and ensuring parenting competency to meet
developmental needs.
4.46 Engagement in school is a protective factor against
harmful drug use and international research, mainly
US-based, indicates that interventions to improve the
school environment may make a contribution to reducing
risk factors for drug use [Loxley et al., 2004]. Preparing
children for school is only a practical strategy for
vulnerable families, where it has shown positive effects on
indicators such as academic achievement and readiness.
4.47 Although interventions have been successful in
preventing and delaying pregnancy in young women
[Swann et al., 2003], their outcome in preventing
pre-birth exposure to drug use and drug use problems
in further generations has yet to be demonstrated.
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Tier 2
Tier 2 services are at the frontline of specialist services. Youth orientated services are delivered by practitioners with
specialist youth knowledge and some knowledge of drugs and alcohol. Examples of practitioners include Child and
Adolescent Mental Health Services (CAMHS) staff, voluntary youth services, paediatric and psychology staff,
Connexions personal advisors, YOT workers, and others with a specialist role within universal services.
Interventions that simultaneously address
individual, familial, and extrafamilial
determinants of behaviour and risk factors
in naturalistic environments have shown
success at reducing drug use.
Less cost effective for number of
individuals reached compared with group
or programme approaches but are tailored to
the specific needs of the individual.
High intensity programmes have shown
effects on drug related behaviours.
Some success in preventing escalation of
drug use.
Short term effects. Life skills approaches
evaluated in the US have shown some small
effects.
Little evidence of success.
Generic interventions
Individually targeted
interventions
Family-based
intervention [including
early intervention and
interventions with
children of drug using
parents]
Targeted community
based interventions
Targeted/selective
school based
interventions
Counselling
 
 
 



warrants further research;  * based on practitioner experience [i.e. good practice];  ** medium quality finding;  *** medium to good quality finding;
**** consistent, good quality finding.
Intervention Evidence Grading Nature of evidence
* ** *** ****
Interventions
section 5
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warrants further research;  * based on practitioner experience [i.e. good practice];  ** medium quality finding;  *** medium to good quality finding;
**** consistent, good quality finding.
Interventions continued
Is insufficient alone, should be part of co-
ordinated strategy.
School-based social work schemes have
some effect on drug use. Indirect effects of
absenteeism monitoring.
Many general prevention approaches
should be successful in this population. Key
is accessibility and relevance of services.
Substance use behaviour may be modified
by involvement in multi-component
programmes.
May reduce rates of offending, reoffending
and imprisonment.
Peer led education
Interventions to reduce
absenteeism/exclusion
Specialist interventions
for young BME
populations
Interventions for cared
for youth
Interventions for young
offenders
 
 
 
 
 
Intervention Evidence Grading Nature of evidence
* ** *** ****
GENERIC INTERVENTIONS FOR VULNERABLE
OR AT-RISK YOUNG PEOPLE
Understanding Drug Use
5.1 There is generally no difference between more vulnerable
young people7 and their peers in adaptation to drug use,
and in the ability to reduce levels of drug use. However,
opportunities of exposure to drugs, and attitudes to drugs
and their use are often different.
5.2 Drug use must be considered in the context of other
vulnerabilities such as; disengagement from school; lack
of skills; unemployment; not living with parents; living in
families where drugs are used regularly; living in violent
circumstances; long term illness; developmental and
behavioural disorders; physical and/or sexual abuse;
bereavement; pregnancy, or responsibility for pregnancy.
Effective Practice
5.3 Less 'structured' work is often the most productive in
encouraging young people to discuss sensitive or
personal issues [Bauld et al., 2004]. Drug focused
interventions are most successful when delivered in
conjunction with other intervention techniques
appropriate to the given group. A flexible approach,
which allows for unplanned issues to be addressed,
is vital when working with this group. A successful
intervention is often as likely to be determined by the
quality of the care as adherence to any particular model
of care. However, individual client focused skills must still
be placed in the context of theories about the prevention
techniques being used and how prevention aims with the
intended target group can be achieved. This will support
the sharing of success and good practice.
7 See Edmonds et al., 2005
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5.4 Generic interventions, bringing together different
professions and using multiple techniques, target many of
those dimensions that contribute to the wider spectrum of
risky/problematic behaviours [e.g. involvement in crime,
sexual risk taking], and have shown success at reducing
drug use [e.g. August et al., 2001; Bushell et al., 2002;
Vimpani and Spooner, 2003]. There is the growing
recognition that much of the association between
different problem behaviours arises from the influence of
common risk factors, so if an intervention only addresses
drug use then co-morbid behavioural problems may re-
emerge, often in conjunction with higher levels of drug
use. In general, most research concerning generic
interventions has not examined drug use per se.
However, interventions that simultaneously address
individual, familial, and extrafamilial determinants of
behaviour and risk factors in naturalistic environments
[e.g. home, school, community] have exhibited some
success in preventing drug use and other problematic
behaviours [e.g. Multisystemic Therapy in the US targets
those factors in an individual's social network that
contribute to problematic behaviour]. Such programmes
may also encompass employment programmes,
mentoring, and community regeneration. There is also
some weak evidence for the long-term effectiveness of
generic early interventions, although most of the few
evaluations of programmes for primary school age
children have shown ineffective results so far. Where
success has been observed, parental involvement/
partnership has been shown to be an essential
determinant. Most of those exhibiting positive outcomes
have been selective interventions and focussed on young
children who exhibit emotional or behavioural problems.
One example of a US project that has shown positive
outcomes for drug use is the Early Risers Skills for
Success, which included child and family intervention
targets. Social development and social ecology theories
provided the conceptual foundation for content of the
major intervention components CORE and FLEX,
respectively. CORE was a coordinated set of standardised
child-focused interventions that promoted healthy
development by teaching skills pertinent to emotional
regulation, prosocial peer affiliation, and school
adjustment. This component was delivered within the
context of child- and parent-focused education and skills
training programmes during summer and regular school
year periods. The FLEX component was a family support,
empowerment, and service-brokerage intervention that
was individually tailored in response to the needs of
individual families. Access to services was organised by
home-visiting family advocates who provided
consultation, support, and brief interventions to assist
families in solving daily hardship and stress-related
problems. When more serious basic living and health
problems were identified, family advocates brokered
specialised services with community-based agencies.
5.5 Individually targeted interventions are more [cost]
effective for vulnerable groups who have initiated drug
use [Becker and Roe, 2005]. Successful targeted
interventions also specialise within targeted groups, as
successes at a group level may not indicate success in the
most vulnerable. Whilst tier 2 services generally do not
target drug naive individuals [but may target those at high
risk of initiation] research from the US has suggested that
sometimes grouping users and non users together in
intervention sessions has positive outcomes on behaviour
[Catalano et al., 1998]. For example, targeting high and low
risk individuals together may have the advantage of
enabling high risk individuals to observe and learn
positive behavioural patterns from low risk peers.
Delivery
5.6 Delivery timing is optimal before the transition period in
mid adolescence [Bushell et al., 2002]. This is because
more protective factors exist in early adolescence, and
with age peer relationships are likely to be stronger and
commitment to family activities weakens.
5.7 Multisite evaluations allow analysis of variations in method
and place, and improve design and implementation of
interventions [Sambrano et al., 2005]. These types of
evaluation are designed to compare programme
characteristics, their relation to programme effectiveness,
and common primary data across sites. They lead to the
identification of the relative effectiveness of different
intervention and implementation strategies in real world
settings. They may represent a more efficient approach to
knowledge generation than multisite trials of particular
programme models, as they are placed in the context of real
world practice.They may also overcome some of the [quality]
limitations of community-generated data when evaluating
prevention by meta-analysis. Common instruments on drug
use, prevention exposure, programme fidelity, case study
narratives, and data collection protocols are used across sites.
Interventions are characterised according to the type of
prevention; e.g. behavioural skills, information focussed,
diversionary, affective programmes. Implementation
measures categorise high or low fidelity, and intensity
measures indicate the number of hours/week participant
engaged with intervention. Data are also collected on control
group prevention exposure, i.e. universal or specialist
services not incorporated into the multisite evaluation.
One such example was a large multisite evaluation in the
US, the National Cross Site Evaluation [Sambrano et al., 2005;
Springer et al., 2002]. Overall, the evaluation found no
significant effects of programme participation upon recent
drug use, but the subsequent analyses suggested ways of
locally delivering services and improving approaches.
PEER LED EDUCATION
Effective Practice
5.8 Peer based education, delivered as part of a
multicomponented or comprehensive approach needs
careful consideration of the facilitator used [peer] and
comprehensive training must be provided [Erhard, 1999;
Gottfredson and Wilson, 2003; Midford et al., 2000; Shiner,
2000]. Interventions fail in the absence of good quality
training. Peer outreach and education alone is insufficient
to affect drug use intentions or behaviours, and so should
be part of a co-ordinated strategy. Generally, peer delivery
should only be considered as an addition to already
successful interventions. Where used, peers should be well
matched to the target population [e.g. [ex-] heroin
dependent users are unsuitable for drug abstaining or a
clubbing population]. Inappropriate adult co-facilitation
[e.g. teacher] reduces the effectiveness of peer education.
Poorly implemented peer interventions have the potential
to increase affiliations between youth with a high number
of risk factors, reinforcing attitudes favourable to drug use.
All evidence suggests that this type of approach may be
more beneficial for peer educators than recipients.
Delivery
5.9 Evaluated community-based peer education projects
delivered in the UK have aimed to recruit educators
from socially excluded areas or from targeted BME
communities [Shiner, 2000]. These interventions have
aimed to benefit both peer leaders and recipients of
the peer-led sessions. A strong emphasis is placed on
the personal development of the peer educators
[e.g. personal support in housing, skills and career
development]. On the other hand, school-based
interventions tend to recruit peer educators from
participating schools rather than the wider community.
They usually have relatively more stable background than
the peer leaders of the community projects and tend to
focus more on the delivery of peer-led sessions than
personal development of the peer leaders.
5.10 Process evaluation highlights several key issues for
implementation of peer-led projects [Shiner, 2000]. Firstly,
it is important to support peer educators with non-
educational but essential issues in facilitating a group, for
example, by influencing group dynamics and discipline
without seeming authoritarian. Secondly, it is important to
develop a policy on confidentiality and personal disclosure
about drug use. Peer educators commonly feel
uncomfortable about personal disclosure of drug use as
this may lead to the risk of being labelled as a drug user
[regardless of current abstinence status] and the danger of
giving the impression to the audience that using drugs is
an acceptable activity. Similarly, the policy should cover a
procedure for when and how to intervene if a member of
the target group discloses information about personal drug
use. Peer educators may not be trained counsellors but it is
important that are able to make appropriate suggestions
for suitable sources of help and information. Thirdly, it is
important to consider that the presence of a class teacher
in a peer-led session could inhibit an open and honest
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dialogue among students. External contributors such as
youth workers, drugs workers, or health professionals
could be present during a peer-led session, instead of a
classroom teacher [White et al., 2005]. These groups are
perceived to maintain confidence more than teachers,
although appropriate action should be taken if the health
and welfare of an individual is of concern. Fourthly, peer
leaders may have a lack of knowledge and experience in
leading drug prevention sessions. Therefore, there is a
possibility of peer leaders providing misinformation and/or
missing opportunities to provide relevant information
during a session. Having an external contributor in a peer-
led session, which can help maintain the quality of the
sessions, can also solve this problem
5.11 Shiner [2000] also discussed four valuable aspects of
peer-based approaches. Firstly, drug prevention messages
or information can often also be successfully
disseminated through peer educators' informal networks,
such as school friends. On the other hand, educators can
fill in a role of semi-formal deliverers. For example, a peer
educator from one of the community-based projects
described by Shiner distributed clean needles from a drug
dealer's flat. It is difficult for those who are not actively
involved in the drug scene to carry out this type of
operation. Secondly, the findings indicated that peer
educators recruited from a target BME population
increase the profile of drug prevention services within the
community. Thirdly, the study suggested that young
people commonly regard peer leaders as more credible
than adult educators, which is a valuable promoter of
engagement and retention. Five types of credibility for a
peer educator were described; person-based [e.g. a role
model or respected individual]; role-based [e.g. a youth
educator]; knowledge-based [e.g. accurate and balanced
academic or colloquial knowledge]; approach/message-
based [e.g. interactive techniques]; and experience-based
credibility [e.g. ex-user]. Student peer educators were
rated highly on the first four types of credibility. In
contrast, teachers were lacking in all types of credibility
except person-based credibility. Ex-users and drug
workers were rated highly on knowledge-based
credibility. However, some younger students [12 years
old] reported a low credibility for ex-users, who saw
ex-users as 'untrustworthy'. Holding credibility or adding
value does not necessary mean that the approach is
effective in preventing drug use.
5.12 The use of peer leaders or educators to deliver life skills
approaches increases effectiveness compared with
teacher led programmes [Coggans et al., 2003]. However,
LST peer leaders [but not teachers] had received
intensive drug-related training and on-going briefing
sessions. These special inputs may have resulted in an
increase in the fidelity of implementation8, which in turn
influenced the outcome. In support of this, there is meta-
analytical evidence to suggest that providing they
received equivalent training, different types of peer
providers are equivalent in terms of their effectiveness
[Black et al., 1998].
SPECIALISED SCHOOL AND ALTERNATIVE
EDUCATION PROVISION
Understanding drug use
5.13 Research conducted in a variety of countries has found
that drug use is associated with higher levels of truancy
and other measures of school performance [Hallfors et al.,
2002; Lloyd, 1998; MORI, 2004; Osler et al., 2002; Powis et
al., 1998]. Individual students are more likely to initiate
substance use in schools where truancy is high and
student commitment to school is low. For example, some
UK studies have shown that pupils excluded from
conventional school education are four times more likely
to have used illicit drugs, and five times more likely to be
current drug users than pupils who have not been
excluded [Goulden and Sondhi, 2001; MORI, 2004]. Truants
are thought to be twice as likely to be users of cannabis
or solvents, and three times as likely to report use of
Class A drugs.
5.14 There is no indication that the frequency of problematic
drug use is greater in truants and school excludees than
in the general population. However, drug users in
alternative education provision may face additional
family and social problems [e.g. lack of family members
acting as carers], which may make drug associated
problems more difficult to resolve.
8 Completeness of implementation is an important factor for drug prevention
programme effectiveness.
Effective practice
5.15 Studies of school based 'Life Skills' approaches
conducted in the US have shown some small effects in
vulnerable young people [e.g. Botvin, 1999]. However,
these may work by modulating factors other than what is
generally understood as 'life skills', and so may be
difficult to implement [Coggans et al., 2003]. These
approaches are often school based, and so success is
highly dependent upon inclusive school policies and
commitment to drug prevention, which may exclude
some of the most vulnerable young people. Independent
review of RCTs of life skills approaches suggests that
some statistical analyses and indicators of success are
problematic, and successes may be overstated [Coggans et
al., 2003]. Generally, there has been no assessment made
of outcomes of other [non-drug] factors, such as
educational inclusion, offending, employment, health
behaviours, which may pose greater concern to the
young person than drug use.
5.16 Other interventions for school aged children vulnerable to
drug use have also shown short term effects. The Opening
Doors programme [based in Canada] was a 10 week
indicated prevention intervention delivered to at risk
children during the transition between primary and
secondary school [De Witt et al., 1998]. Programme
participants were selected for inclusion by a screening
questionnaire. There were four risk factor categories and
those children who scored two or more risk factors on at
least two of the four indices were invited to participate. The
programme consisted of 17 interactive sessions [1 - 2 hours
long] delivered to children on drug knowledge and
information, skills training, and stress anger management.
In addition there were concurrent parallel parent
components comprised of evening sessions that aimed to
foster a supportive home environment. This, in turn, was
expected to strengthen what their children had learned at
school and to encourage efforts to make behavioural change.
After adjusting for baseline differences, significant
programme effects were found for risky drinking behaviour
[i.e. five or more drinks per occasion]; cannabis use; attitudes
towards drug use [alcohol, cannabis, and cigarettes];
attitudes towards school; peer pressures to commit violent
acts; and self-reported theft. However, no significant effects
remained at six months follow up which may either suggest
spontaneous behavioural improvement in the control group,
or a decline in protective programme effects.
5.17 Community based truancy interventions have significant
effects upon psychosocial factors, which subsequently
modulate drug use [Milne et al., 2002]. Assessment of
projects conducted in the US show that intensive home
support for vulnerable families resulted in prolonged
educational and social benefits.
5.18 School based social work schemes have been shown to
have some effect on drug use and attendance [Pritchard
and Williams, 2001]. These aim to assist children and their
families to maximise educational and social opportunities,
facilitate the teacher's role in educating and socialising the
child in school, enhance community-school and other
agency collaboration, reduce truancy and criminality, and
reduce exclusion from school. Preliminary cost-benefit
analysis [see Section 7] of one English scheme indicated a
benefit-cost ratio of 2.5:1, indicating a 250% 'saving'
above the cost of the project [ibid].
5.19 Alternative curriculum projects can raise pupils', parents',
and the local communities' perceptions of schooling.
Where feasible to implement [considering the
requirements of the National Curriculum], these have the
potential to promote good attendance and behaviour
among groups of less able, deprived, and disaffected
pupils. The Yale-New Haven Primary Prevention Project
targeted entire schools at risk [including poor
attendance] and brought together parents, teachers,
pupils and mental health leaders through the use of key
components [Comer, 1988]:
 The establishment of a school advisory council to
manage problems pertaining to school social climate.
 Parent participation was encouraged through
participation on the advisory council, and part time
employment and volunteer activity opportunities in
the school.
 Mental health teams were developed to provide
assessment and treatment planning for children
referred for academic or behavioural problems.
The alternative curriculum and staff development
programme were developed based on student
achievement and concerns from school staff and parents.
Whilst weak, evidence suggested that for participants,
educational achievement increased from 18 months
behind year level, to on par with year level.
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5.20 Monitoring schemes [e.g. 'Traffic light'] reduce exclusion
and identify those at risk of substance use [Reid, 2003].
This type of system monitors attendance and categories
of absenteeism are colour coded; red group represents
the most serious cases; blue, less serious or erratic
attendance, yellow, occasional absenteeism, green,
regular attendance. Using such a staged approach has
been shown to reduce exclusion rates.
INTERVENTIONS FOR CARED FOR YOUTH
Understanding drug use
5.21 Studies conducted in the US suggest that most of the
increase in demand for foster care seen over the last 15
years is due to parental drug use [Magura and Laudet,
1996]. The largest increases in fostering incidence have
been observed in the 0-2 years age category, which would
include infants exposed to drugs in utero who may
subsequently be at risk from developmental problems.
In US studies, two thirds of children placed into foster
care soon after birth as a result of maternal drug use were
still in care two years later [Smith, 2003].
5.22 Looked after children tend to report higher levels of drug
use, consume drugs more frequently, and are initiated
into drug use at a younger age than the general
population [Ward, 1998]. Compared with the general
youth population, young people in care have relatively
high levels of illicit drug use. Use of crack cocaine and
heroin is significantly higher among young people in care
than the general population. Looked after young people
initiate drug use at an early age, which has been
correlated to problematic drug use.
5.23 Steadily lower levels of drug consumption have been
reported as young people assumed/approached
independent living status [Ward, 1998; Ward et al., 2003].
When planned as part of the care leaving transition,
practical responsibilities such as household management
and childcare responsibilities may encourage more
responsible levels of drug consumption. However,
periods of transition in hostels, and premature or poorly
planned movement to independent living can lead to
increased levels of drug use.
5.24 Introduction of screening questions by care institutions
during 2005/06 will help to identify those young people
with drug misuse related needs. The DfES recommends
that data collected includes the number of all children
looked after for at least 12 months who were identified as
having a substance misuse problem during the year; the
number of these children who received an intervention
for their substance misuse problem during the year; and
the number of these children who refused an offered
intervention [DfES, 2004].
Effective practice
5.25 Provision of suitable training for staff in residential units
can have a measurable impact on how drug related issues
are addressed [Bauld et al., 2004]. In one analysis,
differences were demonstrated between staff who had
been on a dedicated training course and those who had
not in relation to their approach and levels of confidence
in dealing with drugs and young people in care. The
former group preferred harm reduction approaches,
whilst the latter abstinence.
5.26 The substance use behaviour of institutionalised youth,
including those in foster care, may be modified by
involvement in multi-component programmes
incorporating group education, counselling and outreach
work. In a large, multi-site intervention Morehouse and
Tobler [2000] reported short-term efficacy of the
Residential Student Assistance Program [RSAP] across a
broad age range of 13 to 19 years within foster care, youth
justice and psychiatric facilities. RSAP was effective in
both reducing and preventing alcohol and other drug use
across the settings studied. A dose-response relationship
was also established with young people in the high dose
treatment group showing significantly larger reductions in
frequency and intensity of substance use. However, the
intensity of a programme does not generally correlate
with programme outcomes [Cuijpers, 2002a, b].
Delivery
5.27 Holistic approaches are responded to with more
enthusiasm than those focussing solely on drug use
[Ward et al., 2003]. In the context of other problems facing
young people within the care system or leaving care, drug
use may be considered less important. Any interventions
should be part of more general planning, embracing
issues such as housing, employment and training based
on a comprehensive needs assessment.
FAMILY BASED INTERVENTIONS [INCLUDING
INTERVENTIONS AIMED AT CHILDREN IN
DRUG USING FAMILIES]
Understanding drug use
5.28 It is estimated that there are between 250,000 and
350,000 children in the UK affected by parental drug
abuse, representing 2-3% of all under 16 years olds
[ACMD, 2003]. In such families it has been estimated that
approximately 37% of fathers are still living with their
children, compared to 64% of mothers [Meier et al., 2004].
The more severe the drug use disorder, the more likely it
is that a parent would be separated from their children.
In studies from the US examining characteristics of
parenting status by sex it was indicated that, although a
greater proportion of women were the parent of at least
one biological child, there were far more fathers than
mothers within the study cohort [Johnson and Pandina,
2001]. Among the parents, fathers were more likely to
have been abusing opioids when they first became a
parent, and they were more likely to be living away from
their children. There were no significant sex differences in
the number of children or the average age of children.
Similarly, in England and Wales, of drug users presenting
to treatment services over a five-year period [1996-2000],
on average there were 2.07 children per father and 2.05
per mother [Meier et al., 2004].
5.29 Drug use in the family influences future individual drug
using behaviours, although the exact relationship is
unclear. Research indicates that generally, children of
drug-dependent parents experience a heightened risk of
substance use, abuse, and dependence in later adolescent
[Barnard, 2005; Johnson and Pandina, 2001]. Drug use per
se is not necessarily increased directly; it is most likely
through complex indirect means such as family drug use
influencing the child's choice of peer group and/or drug
using behaviours [Bancroft et al., 2004]. For example,
although parental problematic drug use is associated with
adolescent use, this association is attenuated by strong
family cohesion [Hoffman and Cerbone, 2002]. Affective
disorders among parents [e.g. anxiety, depression] are
associated with a higher risk of alcohol, but not drug use
in offspring [Kelley and Fals-Stewart, 2004]. The
associations are stronger in the presence of lower stress
and higher self-esteem in the children. Paradoxically,
problematic drug use is also associated more strongly
with offspring drug and alcohol use when levels of
parental use are lower. Hence, some unobserved
mechanism that may involve physiological sensitivities to
drugs and alcohol appears to put children of parents with
drug problems at particular risk of drug and alcohol use.
5.30 Siblings of problem drug users may be at an elevated risk
of developing problems with drugs. Research undertaken
in the US has identified that younger brothers or sisters
of drug users are at an increased risk of drug exposure
and drug initiation, but this is through complex means
not entirely related to exposure opportunity [Bahr et al.,
2003]. Qualitative studies undertaken in the UK of
problem drug use within families found that most
siblings of problem drug users questioned had been
exposed to drug use in some form [Bancroft et al., 2004;
Barnard, 2005]. However, despite this, exposure did not
necessarily result in a greater risk of initiation of drug use.
5.31 Parenting in the context of problematic drug use places
children at increased risk of physical harm and negative
social and developmental outcomes [for reviews see ACMD,
2003; Barnard and McKeganey, 2003; Keen and Alison, 2001].
Illegalities and uncertainties associated with problematic
drug use greatly complicate the provision of a safe and
nurturing environment for children to grow up in.
Household routines may be undermined and children's
needs accorded less priority, leaving them vulnerable to
not being properly fed, clothed or cared for. The medical
needs of children may be left unattended by parents.
Associations between child neglect or abuse and substance
misuse by parents have regularly been observed by
practitioners in the UK and the US. Parental problem drug
use, alongside parental misuse of alcohol, has been shown
to be one of the most likely reasons for children being
received into the care system [see section 5.21]. Children of
drug users are at elevated risk of behavioural problems in
childhood. There is evidence that children may also be
increasingly likely to develop behavioural disorders such as
Attention Deficit Hyperactivity Disorder [ADHD].
Population studies from the US suggest that children who
live with drug using fathers may be more likely to have a
lifetime psychiatric diagnosis compared with other types of
family [e.g. 53% versus 25% in alcohol abusing homes and
10% in non-substance-abusing homes] [Hoffman and
Cerbone, 2002]. Compared to children in the other groups,
children in drug using homes were more than twice as
likely to exhibit clinical levels of negative behavioural
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symptoms. Children living with drug using fathers were
more likely to experience a lifetime psychiatric disorder
and more negative behaviours compared to children living
with an alcohol abusing father or non-substance-abusing
parents [Cooke et al., 2004].
5.32 There is an acknowledgement that parental
preoccupation with drugs can be detrimental for parent-
child relationships [Hoffman and Cebone, 2002; Cooke et al.,
2004]. For example, children of drug users may report
reduced quality of attachment to their parental figures,
and with siblings. Children of drug users also have higher
rates of separation from parents, because of the long-
term nature of recovery from drug dependence and the
potential for relapse. This may be repeated due to cycles
of abstinence and relapse. Drug using parents have been
reported to be more likely to display aggressive
parenting, and this is amplified when linked to other risk
factors such as maternal domestic abuse.
5.33 Parental drug abuse has long term implications for a
child's development and transition into adult life
[Bancroft et al., 2004; Brook et al., 2003]. Children are at
risk from emotional and physical neglect as they grow up
and are at risk from developing emotional and social
problems later in life. Drug use within pregnancy also has
developmental consequences [see Nulman et al., 1994].
The timing of teratogenic insults in relation to foetal
development is critical in determining the type and
extent of the damage produced. Women who are
dependent upon drugs may not cease use when they
become pregnant. Drug exposed newborns may exhibit
reductions in birth weight and head circumference [an
indirect measure of brain size], and be at increased risk
from structural malformations. Exposure to some drugs
during pregnancy may lead to long lasting cognitive
changes in the newborn, who may show abnormalities in
learning and other behavioural changes, including
sensory modalities. Offspring of opiate dependent
mothers show withdrawal syndromes, although this has
not yet been demonstrated with cocaine [Neuspiel and
Hamel, 1991].
Effective practice
5.34 In the US, family focussed interventions have been found
to have some success, or additive effects to already
successful interventions [Kumpfer and Alvarado, 2003;
Vimpani, 2005]. High intensity, family focussed
prevention [e.g. Adolescent Transition Program,
Multidimensional Family Therapy] can improve family
relationships, and often have positive effects on school
behaviour. Whilst not all have positive or direct effects on
drug use they may target those family factors that make
young people vulnerable in the first place. In addition, a
focus on parental skills often affects parental drug use
more than children's, which may reduce some of the
associated burdens in the family. However, it is still
important to incorporate child-focussed sessions into
programmes, as familial factors are an important
determinant of young people's subsequent [drug using]
behaviour. Parent management training [based on
cognitive social learning theory] is the most widely used
parent education technique. Using these approaches,
studies report improvements in outcomes such as child
development, relationships, clarity of family rules,
increased knowledge of child behavioural management
principles, and increased family communication of
problems [Vimpani, 2005]. There are some suggestions of
greater cost effectiveness compared to other evaluated
early intervention approaches. However, these, studies,
like most in the field, have relied on small sample size
and there is a lack of assessment of anything other than
post treatment effects [i.e. not longitudinal or prospective
study designs].
5.35 There are always difficulties in family recruitment and
retention, particular with early interventions [Kumpfer and
Alvarado, 2003; Vimpani, 2005]. Engagement is often
dependent upon the extent to which families feel
empowered by the intervention. Compliance is often
lower in high risk families, but retention rates have been
reported to be higher for family skills training than
parent-only programmes. This could be attributed to the
involvement of children or attempts to reduce barriers by
including meals, transport and free childcare in family
programmes.
5.36 Targeting programmes to multiple risk parents or families
in juvenile justice settings may be effective at reducing
offending [reviewed by Loxley et al., 2004]. Intensive
interventions based on behavioural, social learning
principles and behavioural parent training have been
demonstrated to reduce offending and incarceration, and
have indirect effects upon drug use. Functional Family
Therapy [a brief [eight hour] family based therapy using
a staged family counselling programme] has
demonstrated reductions in youth justice expenditure.
Critical components of this approach involve reframing
problem attribution away from individual blame, to a
mismatch in family needs. Multisystemic Therapy [see
section 5.4] offers a large component of preventative case
management based on family systems principles
including strategies to enhance individual competence,
tackle peer relationship issues, and to ensure access to
work, education and community resources. Multisystemic
Therapy has also shown reductions in offending and re-
arrests [also refer to interventions for young offenders].
5.37 Strategies aiming to prevent or delay pregnancy in young
and vulnerable mothers may be an effective way of
reducing the risks of teratogenic insults in pregnancy,
so that women can choose to become pregnant when
drug use is under control or being treated. Current sexual
health services aim to delay initiation of sexual activity,
encourage the use of contraception, reduce risky sexual
behaviour and provide access to pregnancy termination
[reviewed by Ellis and Grey, 2004]. Preventative strategies
such as school-based sex education and community
mobilisation have been most successful [Wight et al.,
2002]. There is some evidence to suggest that these
programmes also reduce harmful drug use in vulnerable
young women, which suggests that common risk factors
drive the two types of behaviour [ibid].
5.38 Although well researched, there is limited evidence for
the effectiveness of home-based visits for young drug
using mothers, or drug using women in fertile years.
This type of approach involves a professional developing
a relationship with a family over a period of time, offering
support on infant health and development, maternal
health, and advocacy for service access [Dore et al., 1999].
Research findings warrant cautious optimism regarding
the efficacy of early home intervention among drug-
using women in promoting positive behaviours.
In general, few interventions for drug-using parents have
been subject to rigorous evaluation. However, the authors
of those studies performed have noted that these
interventions have shown that it is possible to recruit and
retain parents, and that some robust and positive
behavioural changes in the domains of drug use and
family management have been reported [Ernst et al.,
1999]. Although most programmes have originated in the
US, experiences of residential, home-visiting, non-
residential programmes and playgroup-based clinics have
led to an outline of issues and dilemmas faced by this
population that are applicable to the UK [Bauld et al.,
2004]. These include balancing trust and acceptance with
intervention when problems are identified, harmonising
accessibility and flexibility with the provision of child-
focused activities and adult education, finding a location
that is both suitable and affordable, appropriately
supporting staff, collaborating with other services and
securing adequate funding, including for ongoing
evaluation and monitoring [Bauld et al., 2004,Vimpani and
Spooner, 2003]. Such approaches promote positive
attachment with child, and teaching parenting skills.
There is some evidence for a reduction in parental
substance use and some evidence for lower rates of early
initiation of alcohol and tobacco. The US based Seattle
Birth to 3 programme, for example, which involved
intensive home visitation by paraprofessionals, and
demonstrated positive outcomes for participating
mothers and their children [Grant et al., 2005]. In these
type of approaches there is a need to incorporate
constructivist adult learning principles [i.e. learners
construct knowledge for themselves, each learner
individually constructs meaning as they learn], promoting
clients' growth through their 'zone of proximal
development' [i.e. what is learned with help and what
can be achieved without guidance], and use of enabling
techniques such as scaffolding [i.e. the learner is seen as
constructing an edifice that represents their cognitive
abilities], motivational interviewing and modelling, and
the development of an agenda for change by the nurse in
partnership with the mother.
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5.39 Diversionary pursuits in conjunction with 'issues-based'
work can provide a valuable environment for 'older'
young people affected by parental drug use to voice their
concerns [Bauld et al., 2004]. Such interventions can
provide young people an outlet to discuss issues around
their parent's substance misuse, whilst also learning
more about drug-related issues. Similarly, for younger
children, playgroup based clinics [e.g. based on health,
welfare, and advocacy] assist children in developing
skills, and allows parents to share information and to play
with their children [Denton et al., 2000]. In existing
programmes no demands are usually made regarding
drug use, but support is available to those who request it.
5.40 Intensive family focussed interventions for children of
methadone treated parents have shown positive effects
upon parenting skills and parental drug use [Catalano et
al., 1999]. These type of interventions supplement
methadone treatment with sessions [> 30] of family
training combined with nine months of home-based case
management. The training involved individually tailored
structured cognitive-affective behavioural skills
curriculum, incorporating motivation, discussion, guided
practice, independent practice, and generalisation to
everyday life. Skills training for parents was developed
and included relapse prevention and coping, anger
management, child development, holding family
meetings, and setting clear expectations. Parents were
also taught how to teach their children drug refusal and
problem solving skills and strategies for succeeding in
school. Some skills training sessions involved children in
order to allow parents to practice their new skills in a
controlled environment. One year after the family skills
training, results indicated significant positive changes
among parents, especially in the areas of parent skills,
parent drug use, deviant peers, and family management.
However, few changes were noted in children's
behaviour or drug related attitudes, although other
positive effects were reported in younger children, who
were observed to have greater family involvement with
their parents at the 6 month follow up.
Delivery
5.41 Holistic family approaches, including integration of
courses on parenting skills, may present a way to engage
drug using parents and/or families in programmes
targeted towards children [Banwell et al., 2002].
Involvement may improve adult self-esteem and parent-
child interactions. However, such approaches are likely to
be difficult to manage and implement, and are resource
intensive. Research shows that women with dependent
children are more likely to be retained in treatment
where services provide specialist support for child care
and parenting [Copeland and Hall, 1992]. Such projects
that aim to work with both adults and children will
require staff with specialist skills and knowledge. For
example, adult workers in treatment agencies are rarely
knowledgeable about child protection issues and
recruitment of skilled workers is rarely straightforward
[Bauld et al., 2004]. Adult workers are likely to require
training in relation to identifying appropriate clients
for referral, and more general child protection issues
[Fraser and Seddon, 2003].
INTERVENTIONS FOR YOUNG OFFENDERS
Understanding drug use
5.42 Surveys of young offenders often indicate high levels 
of drug use compared to the general population
[e.g. Hammersley et al., 2003]. Some studies have shown
that male offenders are more likely to be Class A drug
users but the generalisability of these results are limited
by relatively small sample sizes. A proportionate number
of injectors have been identified, but severity of drug use
and offending often varies according to the survey source.
For example, surveys within Youth Offending Institutions
or based on YOT data cannot be accurately compared
with estimate obtained from self-declared offenders in
general population data sets [i.e.Youth Lifestyle Survey].
5.43 Prolificacy of offending may be significantly associated
with drug use, with persistent offenders having the
highest prevalence of use [Goulden and Sondhi, 2001].
Effective practice
5.44 This population particularly benefits from specific
targeting. Whilst specialist drug workers will generally
have access to offenders in police stations, they need to
quickly establish rapport and credibility with the client,
as contact time may be particularly short. There is also the
need for appropriate multi-agency needs assessment and
practice outside the criminal justice system.
5.45 Early preschool interventions combined with home visits
[behavioural family interventions] have been found to be
effective in reducing later onset of criminal behaviour and
drug use [Loxley et al., 2004; Vimpani, 2005]. For example,
the Perry Preschool project in the US offered four half
days of structured pre-school experience combined with
weekly home visits over two years to disadvantaged 3-4
year olds. It aimed to improve a broad range of parenting
skills, particularly non-coercive parenting techniques.
This was an adaptable programme so that the intensity
of the programme could be tailored to the needs of the
client group. In a longitudinal analysis, improved
outcomes in criminal behaviour and conduct disorder
were noted in adolescence/young adulthood. However,
despite these apparent successes, poor family compliance
was reported in particularly high risk groups [10-50%],
which may lead to an overestimation of the success of
this type of approach.
5.46 Diverting young offenders into early intervention services
may reduce rates of re-offending and imprisonment, and
have some impact on drug use. US-based programmes
which have demonstrated some evidence of short-term
effectiveness, have included [Loxley et al., 2004]:
 The Residential Student Assistance Program [RSAP],
a large multi-site intervention aimed at modifying
the substance use behaviour of young people in
criminal justice institutions. Short-term follow-up of
the programme indicated that RSAP was effective in
both reducing and preventing alcohol and other drug
use across settings including juvenile justice facilities.
Participants in the 'high dose' treatment group
showed significantly better reductions in alcohol and
other drug use.
 The Family Empowerment Intervention, which
directly targeted family functioning in young
offenders. At two years follow up, the programme was
shown to be relatively more beneficial at reducing the
frequency of emotional/psychological problems and
cannabis use in cases of serious versus non-serious
offending. Significant reductions in cannabis use were
also reported in the non-serious offending group.
 Mandated entry into family intervention programmes,
such as Functional Family Therapy and Behavioural
Parent Education [see below]. Research has
demonstrated that these programmes may bring
about longer-term reductions in crime and custodial
sentences.
5.47 Targeting programs to multiple risk parents or families in
juvenile justice settings may be effective at reducing
offending [Loxley et al., 2004]. Intensive interventions
based on behavioural, social learning principles and
behavioural parent training have been demonstrated to
reduce offending and incarceration. These types of
intervention often have indirect effects upon drug use by
reducing risk factors associated with initiation. Functional
Family Therapy [a brief [8 hour] family therapy using a
clearly-staged family counselling programme], for
example, has demonstrated reductions in juvenile justice
expenditure. A critical component of this type of
approach involves reframing problem attribution away
from individual blame to a mismatch in family needs.
5.48 A qualitative evaluation of the named drug worker
[NDW] scheme found no clear evidence that the
programme had an impact on drug use [Dillon et al,
2005]. The scheme provided young people in contact with
a Youth Offending Team access to a specialist or 'named'
drugs worker. Assessing the impact of the scheme on
young people's drug use and offending was seen to be
problematic and it was perceived to be difficult to
attribute behaviour change to participation in the NDW
programme. Of note, successful impacts upon offending
were only evident if there was an accompanying
reduction or cessation of drug use.
5.49 Local evaluation of 27 drug and alcohol projects across
the UK highlighted the following interventions as 'not
working particularly well' with young offenders: group
work rather than individual counselling, outreach work
and arrest referral [Hammersley et al., 2004].
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Project workers offering group interventions found them
difficult to implement and reported that inclusion of
substance misuse issues within generic groups for drug
users or offenders would be more appropriate. Outreach
work did not prosper in the projects evaluated. Two
projects offered arrest referral for young people, and
neither reported success. Due to the unique needs of
young offenders, it was concluded in this study that arrest
referral schemes based on the adult model were unlikely
to succeed.
INTERVENTIONS WITH YOUNG PEOPLE IN
BME COMMUNITIES
Understanding drug use
5.50 Some young people from Black and Minority Ethnic
[BME] communities have an increased number of risk
factors that have been shown to predict vulnerability to
drug use, e.g. higher rates of unemployment and lower
levels of household income [ONS, 2005; Bashford et al.,
2003; Wanigaratne et al., 2003]. It is important to note that
drug use and patterns of use varies considerably across
different ethnic groups. One survey of drug use across
these populations identified that drug use by South
Asians was more characterised by use of heroin than
crack, and a wide range of other drugs including ecstasy
and LSD; Black Africans' drug use was characterised by
use of heroin and crack, compared to Black Caribbean use
which was characterised by crack, amphetamine and
ecstasy. Cannabis was the most widely used drug across
all populations. Compared to White British populations,
surveys have indicated generally lower rates of self-
reported BME drug use, but often different patterns of
use, compared to their white peers and young people of
mixed ethnicity. However, under reporting is expected due
to stigmatisation of drug use within some communities.
Effective Practice
5.51 There are clear barriers to service engagement for BME
populations [Fountain et al., 2003]. Services may lack an
understanding of BME cultures and languages, and
therefore, be perceived as inappropriate or inaccessible.
There may be a lack of acknowledgement of drug use
problems within some BME communities and they may
also lack awareness of treatment and prevention services
and/or an understanding of their functions.
5.52 Social influences approaches with 'bicultural
competence' elements [teaching of coping skills for
negotiating between mainstream and traditional cultures
to increase a sense of self-efficacy in both cultures] have
shown effectiveness [see Bledsoe, 2002; Hawkins et al.,
2004; Schinke et al., 2000]:
 The teaching of coping skills for negotiating between
mainstream and traditional cultures to increase a
sense of self-efficacy in both cultures elements has
been shown to be effective.
 Young people who received culturally sensitive skills
training showed positive changes in drug using
behaviour, drug-related knowledge and attitudes,
decision-making skills and interactive abilities compared
to controls. There was also some evidence for a long
term impact on drug use behaviour. However, the
components of individual programmes were diverse
[e.g. presence of booster sessions and some community
involvement], so it is difficult to ascertain which features
were more effective than others.
 Meta-analysis [of US studies] found that there was no
significant difference in programme effectiveness in
changing drug using behaviour, knowledge or
attitudes between programmes with and without
cultural components. However, studies were included
in this analysis if at least 50% of the sample were
youth from BME populations. This leaves a possibility
that 50% of the sample in these studies was White
youth and the cultural components of the
programmes might have had little effect on them.
 This analysis concluded that there were significant
prevention effect differences, according to ethnicity.
Students from African American background
benefited more from programmes that provided
culturally focused activities than those that did not.
Likewise, they received the most positive impact
from programmes with extracurricular activities.
Programmes were more effective among
Hispanic/Latino youth when the programmes
provided refusal skills training. Some cultural
components were more effective in improving
drug-related knowledge than others. Programmes
with 'culturally organised activities' and 'cultural and
spiritual well-being' were significantly more effective
for knowledge gain than programmes without these
components.
 Programmes that featured traditional prevention
approaches were not significantly superior to
programmes that did not use them. These comprised
of a range of common drug prevention interventions
such as affective education [programs and curricula
which attempt to change the values and behaviour of
students], refusal skills training, life skills training,
safety skills training, and extracurricular activities.
Nevertheless, there were some exceptions;
programmes with affective education were
significantly less effective at preventing drug use than
programmes without this component. Conversely,
programmes with refusal skills training had
significantly greater prevention effects than those
without this type of training.
 Theory-based programmes were not more effective at
preventing drug use behaviour or drug-related
attitudes than programmes that were not based on
theories. When each theoretical model was
considered in the context of each outcome, only
problem behaviour theory produced results indicating
ineffectiveness, especially on the outcome of
behaviour. However, it should be noted that this
meta-analysis did not examine the fidelity of
implementation or the quality of these programmes.
Therefore, there is a possibility that low fidelity of
implementation, rather than inappropriateness of
theories, could have affected the result.
Delivery 
5.53 Research with Asian communities has identified that
engaging them in drug prevention activities might best
be achieved through a whole community approach
[Fountain et al., 2003]. The following issues should be
addressed:
 Cultural ownership and leadership.
 Understanding of the communities needs.
 Appropriately trained BME drug workers.
 Services that are in and for the community.
Other Approaches
5.54 There is little evidence for the success of counselling
based interventions in reducing drug use [Durlak, 1998;
Roe and Becker, 2005]. Research evaluations have shown
no effects [community based counselling], decreased
drug use [individual or group based counselling], or
increased use [individual, paired, or grouped based
counselling].
5.55 Community based and community empowerment/
mobilisation programmes have been found to have some
success in preventing escalation of drug use in the US
when delivered as part of a comprehensive
multicomponent programme [Hawkins et al., 2004].
These types of approach, comprising various strategies
[e.g. curriculum-based skills training, training for
teachers, health education for community members,
school-wide environment changes and coordinated care
for users], can take place in several settings with ties to
the community [school, community and youth services].
Adding a community based case manager can improve
co-ordination of necessary services. These approaches
include campaigns to initiate or strengthen an explicit
strategy of coordinated community action aiming to
promote healthy development and prevent harmful drug
use. For example, involving vulnerable young people in
community based activity programmes [e.g. youth club]
enhanced by prevention components, confers protection
against more problematic drug use [e.g. crack cocaine] at
individual and settings levels. Parental engagement is
often increased in communities where such provision
already exists, but not necessarily in prevention settings
enhanced by drug prevention components. There is some
evidence to suggest that community approaches have a
positive impact on young people's alcohol and cannabis
use. However, the poor methodology of evaluation
studies, including a lack of appropriate control groups,
makes judgements of effectiveness inconclusive.
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Tiers 3 & 4
Interventions delivered at tiers 3 and 4 are services provided by specialist teams to respond to the complex needs of
the young person. Tier 4 services are aimed at providing specialist intervention[s] for a particular period of time and
for a specific function.
Whilst there is a growing literature for
effectiveness from studies in adult opiate
users, little is specific to young people. The
evidence suggests that pharmacologically
driven approaches in adults may also be
suitable for younger age groups.
See above.
Evidence from adult services is generally
favourable towards the acceptance and
utility of harm reduction. However, no work
has investigated the role of harm reduction
approaches in reducing problematic drug
use in young people.
Family based therapy has been shown to be
effective in reducing prevalence and
frequency of drug use.
Some evidence of effectiveness. For example,
short session of motivational interviewing
can produce short term reductions in
frequency of cannabis and stimulant use.
No specific literature on preventative role of
tier 4 interventions.
Pharmacological
management
Detoxification
Harm reduction services
Psychological therapies
Brief interventions
Tier 4 interventions
 
 
 
 
 
 
warrants further research;  * based on practitioner experience [i.e. good practice];  ** medium quality finding;  *** medium to good quality finding;
**** consistent, good quality finding.
Intervention Evidence Grading Nature of evidence
* ** *** ****
Interventions
section 6
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Understanding drug use
6.1 Use and misuse of drugs occurs in a developmental and
environmental context and many children and young
people who use substances often have multiple
antecedent and co-occurring mental health, social and
educational problems [Health Advisory Service, 2001].
6.2 Young people in need of tier 3 and 4 services may present
with a complex array of needs and problems, including
homelessness, poor school attendance, offending,
experience of sexual abuse, prostitution, deliberate self-
harm, psychotic illness, anxiety, depression and suicidal
feelings [Crome et al., 2000], in addition to their drug-
related needs.
Effective practice
6.3 Pharmacological interventions should be used only after
consideration of all risk factors [e.g. risk of overdose] and in
conjunction with other types of therapy. Treatment should
be designed to meet the needs of the young person [Health
Advisory Service, 2001; National Treatment Agency, 2005a].
6.4 Psychological therapies, in combination with other
interventions, may be relevant to the treatment of young
substance users [Health Advisory Service, 2001]. There is
growing evidence from the international literature
supporting the effectiveness of supplementing drug
treatment for young people with manualised9 forms of
family therapy [e.g. US-based Addicts and Families
Project] [Loxley et al., 2004]. In addition, out-patient
cognitive-behavioural therapy10 [CBT] has been shown to
be effective in reducing adolescent substance use and
related problems [Waldron and Kaminer, 2004].
6.5 In the US, community-based treatment programmes
[including residential, outpatient and short-term
inpatient programmes] for adolescents have shown some
effectiveness in reducing drug use, including cannabis
and other illicit drug use [Hser et al., 2001]. In addition,
participants in the programmes reported better
psychological adjustment and school performance
following treatment. Longer stays in treatment were
associated with better outcomes.
6.6 Emphasis should be placed on retaining young people in
treatment. Younger drug users, males and those with no
previous experience of treatment have been shown to be
at a higher risk of dropping out of treatment
programmes. Review of a service for adolescent drug
misusers in Stoke-on-Trent found that patients who
dropped out of treatment were more likely to have had
episodes of deliberate self harm, a history of psychiatric
illness, a family history of substance abuse problems,
familial dysfunction, a forensic history and to have left
school early [Crome et al., 2000].
6.7 National guidance recommends that harm reduction
services should be available to young people, separate
from adult services [National Treatment Agency, 2005a].
Information and advice should be provided in relation to
a young person's needs which might include safer drug
use, safer injecting, blood borne viruses, hepatitis B
vaccination, overdose prevention and response to
overdose, and related sexual or physical health advice
[Drugscope and Colin Wright Associates, 2004].
6.8 Evidence suggests that brief interventions may
successfully help young people to moderate their drug use
[McCambridge and Strang, 2004; Marsden et al., 2004], as
well as increasing their knowledge of local services.
6.9 National guidance recommends that tier 4 services
should not be solely about rehabilitation or dependency,
they should also address issues of safety, security or
respite and be flexible services commissioned or
purchased around the needs of the young person
[National Treatment Agency, 2005a]. Further research is
needed to identify which models of care [including
residential placements and foster care] are most effective.
Delivery
6.10 Family therapy has been found to be effective in
engaging and retaining adolescents in treatment.
6.11 Based on responses from 97 DAT areas [Didlock et al., 2005],
the most effective prescribing services were identified as
those that integrated prescribing into existing service
provision [that is, young people received preparation,
interventions, intensive and consistent support during
treatment, and aftercare from a single service].9 An intervention guided by a formal manual
10 Including components such as self-monitoring, avoidance of stimulus clues,
altering reinforcement contingencies and coping skills training to manage and
resist urges to use drugs. The use of modelling, behaviour rehearsal, feedback
and homework assignments during treatment are characteristic of CBT.
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7.1 The consequences of illicit drug use cost the UK economy
billions of pounds each year and divert resources away
from other productive uses [Godfrey et al., 2002]. For
problematic and dependent drug users in England and
Wales, total economic costs range from £2.9 - 5.3 billion.
Including social costs, this rises to between £10.1 - 17.4
billion. Young, non-dependent users, cost health and
criminal justice services around £6 million in 2000, total
social costs have been estimated at £28.8 million. Costs
are not only incurred by individuals, but also by the NHS,
social services, the Police, and the criminal justice system.
Although not yet subject to investigation, the families
and relatives of drug users also bear associated costs.
7.2 From an economic point of view, the drug problem has
an important opportunity cost, the diversion of money
that could have been spent on desirable alternatives.
For example, in the UK it is estimated that illegal drug
taking requires a workforce of about 5,000 customs
officers and 18,000 police personnel who are subsequently
unavailable for other duties [Maynard, 1992].
7.3 Economics has been defined as “the science which studies
human behaviour as a relationship between given ends
and scarce means which have alternative uses” [Robbins,
1935]. Hence, economics is concerned with how society
uses the resources at its disposal to improve the welfare of
individuals among infinite competing potential uses.
7.4 Health economics is the branch of economics applied to
health and health care. At its simplest, economic
evaluation asks whether an investment of all resources
will be less than the stream of benefits that are predicted
to flow from it. If this is the case then social welfare is
improved by such an investment, provided the resources
used could not be better used elsewhere. Putting this
in monetary terms is crucial because it enables
comparison of different programmes even beyond
healthcare [for example, criminal justice programmes].
7.5 Economic thinking is a relatively recent innovation in
drug policy and to date, few good economic evaluations
of drug prevention strategies have been undertaken. This
is despite opportunity costs and the associated trade-offs
often being very apparent in policy making.
7.6 There has been relatively less investment in drug
prevention compared to other ways of addressing drug
problems in the UK, with the largest proportion of
investment channelled towards drug treatment. Figure
7.1 shows the Government's direct annual expenditure
on meeting the aims of the Updated Drug Strategy.
Successful prevention initiatives in young people would
reduce the financial burden of treating problematic drug
use in adulthood.
7.7 Economic evaluation provides an assessment of the
cost-effectiveness/benefit of specific interventions, which
can in turn inform future spending decisions. As well as
deciding the best use of resources it can also help with
finding the best mix of drug prevention programme
inputs [e.g. universal versus targeted prevention] as well
as the optimal level of programme output [e.g. cessation
versus reduction of drug use].
Introduction to the economics
of drug prevention
section 7
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7.8 As more drug prevention programmes may be
implemented in competition with drug treatment and
other approaches, it is becoming increasingly important
to determine which programmes make the best use of
resources.
Personal and external costs of drug use
7.9 The nature of both personal [e.g. health] and external
[e.g. criminal justice, NHS] costs is central to drug policy
and it is important to understand their range and
significance before employing specific economic
evaluation techniques. External costs related to the
consequences of an action by one individual or group as
they fall on others. For example, changes in the patterns
of consumption of illegal drugs, alcohol and tobacco can
determine demands that are made on the healthcare
system related to treatment and ill health.
7.10 Drug and alcohol use also has third-party consequences
[e.g. victims of drug-related acquisitive crime];
in economic terms these are called external costs.
The costs of drug and alcohol use may also include wider,
intangible costs such as fear about drugs and crime in the
community, which may have a negative impact on the
quality of life of many individuals and communities.
Figure 7.2 shows the costs and benefits included in the
evaluation of the Midwestern Prevention Project, a large
US-based community prevention trial [Pentz, 1998].
Figure 7.1:  Trends in government direct annual expenditure on the Drug Strategy
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7.11 Drug markets follow similar economic principles to
normal markets and price in particular acts on both the
supply and the demand for drugs. Like conventional
consumers, non dependent drug users are sensitive to
changes in price [e.g. Sumnall et al., 2004]. However, other
aspects of drug misuse means that additional economic
considerations have to be made when examining 'drugs'
as a commodity.
7.12 Some population groups [e.g. young adults], show a
greater preference for using drugs than others. This
conflicts with traditional economics theories, as with
normal market goods individuals are assumed to look
after their own personal well-being [e.g. not undertaking
activity that could have serious consequences for health]
and posses the full information to do so [e.g. purity of a
drug preparation]. Due to their illicit nature, such
information is not always available regarding the dangers
and problems that can arise from taking drugs.
7.13 Drug dependence also goes against classic economic
theory, as dependent individuals may consume up to a
point where the personal costs resulting from use
exceeds the [perceived] benefits obtained from use
[e.g. pleasurable mental states].
7.14 Preventing drug use raises some interesting dilemmas
for economic evaluation. Individuals may feel that there
is no need for prevention and in economic terms this may
lead to under demand for prevention goods, but
prevention is also sometimes seen as a merit good
[a good that society thinks people should consume or
receive, e.g. drugs education].
7.15 The timing of prevention poses a problem, as unlike
drug treatment, the benefits of success are not [relatively]
immediate or visible. Economic analysis treats future
costs and benefits differently to present ones, and they
are harder to identify and quantify. This may work against
prevention.
Economic evaluation
7.16 There are four main types of economic evaluations,
cost-effectiveness analysis, cost-utility analysis, cost-
benefit analysis and cost-minimisation analysis, as shown
in Table 7.1.
7.17 The results of all types of economic evaluation are
sensitive to the ways in which costs and outcomes are
measured, and caution should be applied when
comparing results across studies.
Figure 7.2:  Costs and benefits included in the evaluation of the Midwestern Prevention Project
 Reduction in daily smoking.
 Reduction in monthly drunkenness.
 Reduction in need for treatment (including
outpatient and inpatient treatment, counseling,
emergency room admission).
 Reduction in family member need for treatment
(including outpatient and inpatient treatment,
counseling, emergency room admission).
 Reduction in perceived smoking at school related
to school policy.
MIDWESTERN PREVENTION PROJECT
BENEFITS COSTS
 Programme development.
 Training.
 Implementation.
 Institutionalisation.
 Research / Evaluation.
ANNUAL REVIEW OF DRUG PREVENTION: THE NATIONAL COLLABORATING CENTRE FOR DRUG PREVENTION46
Cost-effectiveness analysis
7.18 Cost-effectiveness studies use specific end-points and
generally measure parameters in natural units to define a
'successful' outcome [e.g. cost per additional life saved,
cost per prevented drug user].
7.19 It can sometimes be difficult to determine which measure
is most representative of an improvement in outcome
and therefore, a single effectiveness measure does have
limitations.
Cost-utility analysis
7.20 The results of cost-utility analysis [a method derived from
cost-effectiveness analysis] are usually expressed as a cost
per quality adjusted life year [QALY] gained.
7.21 QALYs are a measure of both the quality and quantity
of the years of life a person is expected to have. For
example, 10 years in a health state with quality of life
rated at 0.5 [where 1 is equal to perfect health and 0 is
equal to death] would result in 5 QALYs [equivalent to
5 years in perfect health over the next 10 years].
Table 7.1:  Main types of economic evaluation [from Hoch and Dewa, 2005]
NAME
COST-
EFFECTIVENESS
ANALYSIS
COST-UTILITY
ANALYSIS
COST-BENEFIT
ANALYSIS
COST-
MINIMISATION
ANALYSIS
MEASUREMENT
UNITS FOR EFFECT(S)
One effect measured in
natural units.
Two effects [quality and
length of life] whose
product is taken as
quality-adjusted life years
[QALYs].
All effects measured in
monetary terms.
No effects measured.
STRENGTHS
There is one outcome
and it measured in
natural units.
Patient outcomes
involving both quality
and length of life can be
incorporated in the
analysis.
The net present value
[NPV] is easy to
interpret.
There is only a need to
collect cost data.
LIMITATIONS
 Only one outcome will
represent the effects of a
programme or intervention;
however other outcomes may
be relevant.
 QALY measures vary by
method.
 QALY measures vary by
respondent.
 Society may value a QALY for
different patient groups
differently.
 It is difficult to measure the
value of all health outcomes
in monetary terms.
 There may be moral
objections about the impact
of ability to pay in the process
of valuing the effects.
 Few treatments have identical
outcomes.
 Effect data would need to be
collected to verify the
equivalence assumption.
box 7.1   Example of cost-effectiveness analysis
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Example 1. A cost-effectiveness analysis
The Midwest Prevention Project [MPP] was a large, US community-based prevention trial funded by NIDA involving
communities and schools in the states of Kansas, Missouri and Indiana [Pentz, 1998]. Briefly, the programme consisted of a mass
media campaign, a school programme, a parent programme, community organisation and local policy changes. The costs and
effects of the MPP compared to usual drug education are shown in Table 7.2. The cost of the project was estimated at around $31
per family unit per year compared to 'traditional drug education', which was estimated to cost $6 per student per year. The effects
of the MPP were reported at 5 year follow-up; there was a 12% reduction in daily smoking, 2.5% reduction in monthly
drunkenness and a 2.5% reduction in heavy cannabis use. Traditional drug education was assumed to have little or no effect on
these outcomes.
From the results shown in Table 7.2, we can calculate the incremental cost-effectiveness ratio [ICER], which allows us
to examine the additional costs that the MPP imposes over traditional drug education, compared with the additional effects it
delivers. In this example, compared with traditional drug education, the Midwestern Prevention Programme costs an average of
$2.08 additional dollars to achieve a net reduction in daily smoking, $10 additional dollars to achieve a net reduction in monthly
drunkenness and $10 additional dollars to achieve a net reduction in heavy cannabis use.
Table 7.2:  Results from an economic evaluation of the Midwest Prevention Project
VARIABLES
AVERAGE COST
AVERAGE EFFECT
REDUCTION IN
DAILY SMOKING
REDUCTION IN
MONTHLY
DRUNKENNESS
REDUCTION IN
CANNABIS USE
ICER1
ICER2
ICER3
INCREMENTAL ANALYSIS
C
E1
E2
E3
C/ E1
C/ E2
C/E3
$25/12 = $2.08
$25/2.5 = $10
$25/2.5 = $10
TRADITIONAL
DRUG
EDUCATION
$6
0
0
0
EXTRA COST
(C)
$25
-
-
-
-
-
-
 Is used to denote incremental costs and effects.
EXTRA EFFECT
(C)
-
12%
2.5%
2.5%
-
-
-
MMP
$31
12%
2.5%
2.5%
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Cost-benefit analysis
7.22 A common method used to evaluate drug prevention
studies is cost-benefit analysis, which relies on the
conversion of all benefits into monetary values.This type of
analysis usually provides a 'return on investment' estimate,
in the form of a benefit-cost ratio [BCR] or net present
value [NPV], which can be useful for investment decisions.
7.23 The BCR is simply a ratio of benefits to costs and an NPV
is calculated by subtracting costs from benefits, taking
into account the discount factor [used to value future
costs and benefits in terms of present values]. An NPV>0
indicates that a programme is worthwhile. Both
formulations rely on capturing all the relevant costs and
benefits of an intervention or programme.
7.24 Table 7.4 presents an overview of 12 cost-benefit
analyses, which have been undertaken in the field of
drug and alcohol prevention. All but one of these studies
[the Focus on Families programme] showed positive
BCRs or NPVs, meaning that the benefits of the
programme to society outweighed its costs.
7.25 Table 7.4 also shows the different types of costs avoided
and unit programme costs incurred. BCRs at the whole
programme level ranged from 1.69 to 19.64 with NPVs of
<0 to ~$2,386. That is, for every dollar spent on
prevention it is expected to save between $1.69 and
$19.64 in benefits gained for this selection of studies.
7.26 This table is intended to give an overview of the cost-
benefit analyses in the field of drug and alcohol prevention
and examples of how costs and benefits are calculated. The
variability in the savings arises because of [amongst other
issues] the differences in how costs and benefits were
calculated, which costs and benefits were included in the
studies, and the differences in the populations targeted.
For this reason the findings of the individual analyses
should be not compared to one another or used as a
means to select the most efficient programme.
box 7.2   Example of cost-utility analysis
Example 2. A cost-utility analysis
Results from two Dutch heroin trials comparing co-prescription of heroin with prescription of oral methadone [Dijkgraaf et al.,
2005] are shown above. The study found that co-prescription of heroin cost less [total cost savings of €12,793] and provided more
QALYs compared to oral methadone alone.
Co-prescription of heroin generated 0.79 QALYs and methadone alone, 0.73 QALYs, giving a difference of 0.06 QALYs. This is
equivalent to an additional 21 days of perfect health [0.06 x 365] for those receiving co-prescription of heroin. Compared to the
prescription of methadone alone, co-prescription of heroin was cost saving as savings for law enforcement and victim damage
offset the higher costs of treatment.
Table 7.3:  Results from an economic evaluation of the co-prescription of heroin and methadone
INCREMENTAL ANALYSIS
VARIABLES
AVERAGE COST
AVERAGE EFFECT
[QALY]
ICER1
C
E
C/ E
METHADONE
ALONE
€50,560
0.73
EXTRA COST
(C)
-€12,793
-
-
EXTRA EFFECT
(C)
-
0.06
-
METHADONE
PLUS HEROIN
€37,767
0.79
 Is used to denote incremental costs and effects.
<€0
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Table 7.4 Examples of cost-benefit analyses in the drug and alcohol prevention field
STUDY
IOWA
STRENGTHENING
FAMILIES
PROGRAMME
PREPARING FOR
THE DRUG-FREE
YEARS
NEEDLE AND
SYRINGE
PROGRAMME IN
AUSTRALIA
LIFE SKILLS
TRAINING
COMMUNITY
TRIALS PROJECT
'AN OUNCE OF
PREVENTION, A
POUND OF
UNCERTAINTY'
'FOCUS ON
FAMILIES'
PROGRAMME
[NIDA]
ELMIRA
PRENATAL EARLY
INFANT PROJECT
[PEIP]
PERRY
PRESCHOOL
PROJECT [PPP]
MACROSCOPIC
ECONOMIC
APPROACH 
MID-WESTERN
PREVENTION
PROGRAMME
[MPP] 'PROJECT
STAR' 
HIGH/SCOPE
PERRY PRE-
SCHOOL
AUTHOR(S)
Spoth et al., 2002
Spoth et al., 2002
Health Outcomes
International Pty
Ltd
Swisher 2001
Holder et al.,
2000
Caulkins et al.,
1999
Plotnick et al.,
1998
Karoly et al., 1998
Karoly et al., 1998
Kim et al., 1995
Pentz 1998
Schweinhart
et al., 1993
Full references available in the forthcoming report [Fordham et al, 2006]
TARGET
SUBSTANCE(S)
OR
CONSUMER
Alcohol [Parents
and students]
Alcohol [Parents]
Intravenous drug
users
Cigarette
Smokers
Alcohol
Cocaine,
cannabis &
alcohol
Heroin
All drugs
All drugs
All illicit drugs
Cigarettes,
alcohol and
cannabis
All drugs
UNIT COST
(US$)
$880/family
$710/family
Av. 0.72
A$cents/needle
$2,850
Not reported
$150
~$3,400
$14,700/child
$14,700/child
N/A
$108/
participant
$800/family
$12,356
SAVING BENEFIT
CATEGORIES
Not reported
Not reported
HIV/HCV treatment
costs avoided; QALYs
gained
Health care costs
Legal, medical and
administrative caused by
RTAs [over 4 years]
Healthcare, productivity
and crime
Healthcare, productivity,
accidents, domestic
violence, crime
Productivity gains, tax
revenue, crimes avoided,
Social care savings
Productivity gains, tax
revenue, crimes avoided,
Social care savings
Healthcare, crime,
productivity and
premature death
Savings based on
standard costs per
smoker, alcohol and
marijuana abuser
Productivity gains, tax
revenue, crimes avoided,
social care savings
REPORTED
BCR
$9.60 per $1
$5.85 per $12
NPV
[A$million]
2386 [5%
discount rate]
19.64
2.88
Cocaine: 2.40
Cannabis: 5.60
Alcohol: 2.00
At 6 months
NPV<0
400
2.0
15.0
At 5 yrs
Cigarettes: 8.12
Alcohol: 1.69
Cannabis: 1.69
8.74
TYPE OF
INTERVENTION
Family skills training
Family skills training
Needle/Syringe
Exchange
Smoking cessation
hypothetical model
Environmental control
in local community
School-based drug
prevention based on
Alert  & LST
programmes.
Prevention of relapse by
methadone treatment
using social
development model
Home-based parental
education by nurse
Special educational
activities in schools
Regression and
longitudinal analysis of
US Household Survey
data
School-based drugs
prevention programme
in 200 communities over
6 yrs
School and home-
based educational
information for high-
risk families
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Implications and recommendations
7.27 Economic evaluation offers the opportunity to inform
planners of drug prevention policy and services, and
enable them to be more efficient with, and to prioritise,
the finite resources available for future implementation.
However, to date, the application of economic principles
and analysis in the drug prevention field has not been
fully exploited in the UK.
7.28 There are still a number of unresolved issues and
challenges which may continue to hinder the
development of economic methods in the drug
prevention field, particularly around determining suitable
programme outcomes, and which costs and benefits to
include in evaluations.
7.29 Further investment in research into the economics of
drug prevention may help to address the issues outlined.
There is the need for clear guidance to be developed on
which techniques should be used and in what
circumstances to evaluate the costs and benefits of drug
prevention programmes.
7.30 Policy and decision makers in the drug prevention field
should be encouraged to develop an understanding of
good practice in economic evaluation, in addition to
relevant critical appraisal skills. The methodology for
undertaking evaluations of healthcare interventions is
well developed and applicable to public health
interventions such as drug prevention.
This chapter is adapted from a forthcoming [2006] report
written by Dr Richard Fordham, University of East Anglia,
in collaboration with the NCCDP [see Fordham R, Jones L,
Sumnall HR, McVeigh J & Bellis MA [2006] The economics of drug
prevention: An introduction to the issues. Liverpool, NCCDP].
ANNUAL REVIEW OF DRUG PREVENTION: THE NATIONAL COLLABORATING CENTRE FOR DRUG PREVENTION 51
8.1 Evidence-based practice reduces the reliance on intuition
or unsystematic experience as grounds for professional
decision-making, and emphasises the examination of
evidence from research. Evidence-based practice requires
new skills of the drug professional, including efficient
literature-searching, and critical appraisal. For many years
there was the assumption that when research information
was made available it was accessed by practitioners,
appraised and then automatically applied in practice
[Centre for Reviews and Dissemination, 1999]. In a review of
evaluation reports of prevention initiatives conducted by
many local drug prevention projects [McGrath et al., 2006b]
it was evident that most were evidenced on an intuitive
level about effective practice, or otherwise referenced
questionable research evidence and approaches.
8.2 Whilst this report, and others like it, presents
recommendations and statements about the most
effective means of conducting drug prevention, it is
important to consider how this information can
subsequently be used to inform current practice and how
it can be used to develop initiatives in the future.
An approach which is evidence-based per se may not
automatically succeed if the environment in which it is to
be used has not been fully considered.
8.3 The research literature makes a distinction between
communications that increase awareness and those that
actually bring about changes in practice. Whilst knowledge
of a practice guideline or a research based recommendation
is important, it is rarely, by itself, sufficient to change
practice. Extrapedagogical barriers may also arise through
strategic directives and inter-professional politics. This
distinction is helpful in understanding that dissemination
and implementation may be considered as a spectrum of
activity, where dissemination involves raising awareness of
research messages [such as receipt of briefings and reports
such as this] and implementation involves getting the
findings of research adopted into practice [i.e. evidence-
based practice].
8.4 Although the evidence base highlights [small to
moderate] successes in some prevention approaches, it is
pertinent to consider whether theory and research driven
programmes can be successfully implemented in practice.
This has been described as the efficacy-effectiveness
interface [i.e. referring to the power of an intervention to
produce an effect and subsequent production of the
desired effect in practice] and requires investigation in its
own right [August et al., 2004]. Key factors characterising
research based practice and its application are discussed
in Evidence into Practice: drug prevention review
authored by the NCCDP [Sumnall et al., 2006], and
published by NICE. Briefly, to improve the chances of
successful implementation there are a series of factors,
drivers, barriers, and challenges that need to be
considered. These include: 
 Client factors - e.g. the nature of the target group and
their specific needs, comparison with the population
that the original research data was collected from.
 Practitioner factors - e.g. training needs and work
focus of service deliverers; process and fidelity of
implementation.
 Structural factors - e.g. current service provision and
gaps, local strategies, partner organisations and
champions, multi-agency working.
 Political factors and national drivers - e.g. National
Drugs Strategy, local priorities.
Evidence into practice
section 8
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8.5 Careful consideration of these factors provides a
framework for strategic planning and programme
delivery [Kelly et al., 2003]. Success often depends upon
practitioner knowledge of local population groups/
settings and health improvement needs. Whilst the
scientific evidence often provides a framework of
plausibility for prevention interventions, practitioner
knowledge and utilisation provide a basis for
understanding the likelihood of success of particular
interventions. However, it is not always possible to rely
on traditional sources of evidence [i.e. peer reviewed
academic texts] in order to complete our understanding
of these, as they are rarely available.
TABLE
Table 8.1: Summary of considerations when implementing evidence based drug prevention
[adapted from Sumnall et al., 2006]
CONSIDERATION ISSUES
This includes: the National Drugs Strategy, The Drugs Bill; Every Child Matters: Change for
Children; Hidden Harm; Choosing Health: making healthier choices easier; National Service
Framework for children, young people and maternity services; Drugs Guidance for Schools;
D[A]AT young people's plans; National Healthy Schools Programme; National Curriculum.
Co-ordinated local working is needed to ensure consistency in the evidence based approach
across organisations and to link in with relevant local strategies including: Children's Fund
delivery plans, parenting strategies, the young people's substance misuse strategy; the alcohol
harm reduction strategy; Connexions business plans, Healthy Schools partnership plans, crime
reduction strategies, Prevent and Deter strategy, Education Development Plans; Teenage
Pregnancy strategy; Children and Young People's Plan.
Reviews and summaries of data are available to drugs professionals from organisations such as
the NCCDP, NICE and the Drug Strategy Directorate, as well as from the academic literature
and databases like EMCDDA and NIDA. Critical appraisal and review skills are needed in order
to successfully extract practice theory from primary research papers.
Find out if strategies are based on evidence-based interventions [via peer reviewed sources such
as DEPIS and EDDRA]. Despite their apparent success, consider whether US programmes
[where the majority of evidence is generated] can be transferred to a UK context because of
differences in social and community structures, population characteristics, policy etc.
Needs assessment studies and consultation with target groups will identify any gaps. Inclusive,
creative thinking will offer solutions to fill these gaps.
Existing strategic partnerships and delivery plans need to be taken into account when
introducing new ways of working.
These need to be identified and supported. They include members of community groups, youth
workers and teachers.
Include the effectiveness of the primary/secondary care interface, economics, judicial policy and
practice and local education.
Implementation of evidence-based practice is likely to have funding implications and there will
be areas where money can be saved [for example, by closing ineffective programmes]. Start-up,
staff recruitment and continued professional development, evaluation and dissemination of
findings all need to be well resourced.
Interventions may need to overcome cultural, organisational and individual barriers to change.
Who is likely to be involved and what are their skills and competencies? Do they need additional
training and education? Do people need to be recruited? Will new roles and career paths be
required?
DOES THE APPROACH
CORRESPOND TO NATIONAL
GOVERNMENT STRATEGIES
AND PRIORITIES?
DOES THE APPROACH
CORRESPOND TO LOCAL
GOVERNMENT STRATEGIES
AND PRIORITIES?
IS THE APPROACH TAKEN
FROM CURRENT EVIDENCE?
HOW HAS THAT EVIDENCE
BEEN APPRAISED?
EXISTING EXAMPLES OF
'BEST PRACTICE'
WILL THE APPROACH ADDRESS
GAPS IN SERVICE PROVISION
LOCAL PARTNER
ORGANISATIONS
LOCAL CHAMPIONS 
KEY INFLUENCES
RESOURCES
BARRIERS 
WORKFORCE ISSUES
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The purpose of this annual review was to build upon the three
previous NCCDP briefings [Edmonds et al., 2005; Burrell et al.,
2005; Jones et al., 2006] by presenting, categorising, and grading
research findings.
Overall, the report highlights the general need for improved
research and evaluation in the field of drug prevention. In
particular, there is a need to foster a culture of research in
relation to interventions and programmes that are delivered at
tiers 2, 3 and 4, as currently few recommendations can be made
about effective practice at these levels in the UK. Gaps in the
evidence base have been highlighted, and suggestions made as
to how different professional groups may address them. Despite
this cautionary note, this report has highlighted strategies and
interventions with the potential for, or proof of effectiveness.
Whilst much excellent work is taking place with young people
in the UK it is important that successes are shared in a robust
and systematic way and that new projects are designed with
reference to the evidence base. It is clear that a combination
of professional skills and adherence to prevention theory are
pre-requisites for success. Intuitive practice may offer short-
term successes, but in order to maintain success and share
learning across the field then it is important that more
comprehensive approaches to prevention practice are
developed. It is important that not only do we challenge current
practice, but also the evidence from which it may have been
derived. Some interventions may be adhering to models that
have been shown to be ineffective, or even to have opposite
effects than intended, others may offer chance for success but
be economically unfeasible.
Over the next 12 months, the NCCDP aims to support drug
prevention in the UK by offering:
 A web site offering drug prevention resources to a
wide range of professionals.
 An information service providing tailored overviews
of the drug prevention evidence base.
 Reports on key drug prevention issues, such as the
role of employers, media, and the work place.
 A decision making tool enabling quick and easy
access to evidence underpinning key interventions
and national policies.
 Research and evaluation toolkits, offering guidance
and advice to assist drug services to conduct their
own project evaluations.
Next steps
section 9
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